Hugging Face's logo

Datasets:
databio
/
term-knowledge

Modalities:
Text
Formats:
csv
Size:
1K - 10K
Libraries:
Datasets
pandas
Dataset card Data Studio Files Community
1
term-knowledge / homo_sapiens_cell_line_incomplete.tsv
ClaudeHu05's picture
ClaudeHu05
Upload homo_sapiens_cell_line_incomplete.tsv
63d9254 verified
raw
history blame contribute delete
167 kB
 BTO_0001948 JURKAT E-6.1 cell Human, blood, leukemia, T cell line, clone E6.1.
EFO_0002796 Jurkat A cell line derived from human T cell acute lymphoblastic leukemia.
EFO_0022656 J.CaM1.6 Human T lymphoblast cell line
CLO_0010521 GM08388 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM ATAXIA-TELANGIECTASIA; AT
CLO_0010523 GM08390 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM ATAXIA-TELANGIECTASIA; AT
CLO_0010526 GM08398 APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0010557 GM08436 ATAXIA-TELANGIECTASIA; AT ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
CLO_0011234 GM08931 ATAXIA-TELANGIECTASIA; AT
CLO_0011235 GM08930 ATAXIA-TELANGIECTASIA; AT
CLO_0011237 GM08928 ATAXIA-TELANGIECTASIA; AT
CLO_0011391 GM09585 ATAXIA-TELANGIECTASIA MUTATED GENE; ATM ATAXIA-TELANGIECTASIA; AT
CLO_0011394 GM09583 ATAXIA-TELANGIECTASIA; AT
CLO_0011436 GM09581 ATAXIA-TELANGIECTASIA; AT
CLO_0011438 GM09579 ATAXIA-TELANGIECTASIA; AT
CLO_0012496 ND03432 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0013077 GM17289 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013080 GM17288 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013082 GM17287 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013086 GM17286 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013090 GM17285 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013092 GM17284 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013094 GM17282 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013095 GM17283 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013096 GM17280 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CLO_0013097 GM17281 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200
CLO_0013124 GM17296 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013127 GM17295 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013135 GM17291 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013136 GM17292 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013137 GM17293 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013138 GM17294 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013140 GM17290 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013163 GM17265 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013168 GM17264 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013169 GM17263 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013173 GM17262 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013176 GM17269 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013177 GM17268 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013179 GM17267 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013181 GM17266 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013182 GM17260 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013183 GM17261 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013193 GM17274 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013197 GM17273 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013199 GM17276 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013202 GM17275 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013204 GM17278 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013208 GM17277 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013210 GM17279 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013212 GM17270 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013213 GM17271 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013214 GM17272 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013751 GM17180 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013752 GM17184 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013753 GM17183 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013754 GM17182 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013755 GM17181 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013775 GM17187 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013777 GM17188 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013781 GM17185 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013784 GM17186 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013790 GM17189 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013793 GM17191 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013794 GM17190 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013795 GM17193 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013796 GM17192 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013797 GM17195 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013798 GM17194 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013816 GM17196 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013818 GM17197 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013823 GM17198 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013826 GM17199 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013833 GM17206 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013834 GM17205 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013835 GM17204 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013836 GM17203 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013837 GM17202 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013839 GM17201 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013840 GM17200 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013875 GM17209 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013881 GM17207 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013884 GM17208 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013885 GM17215 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013886 GM17214 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013887 GM17217 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013888 GM17216 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013890 GM17211 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013891 GM17210 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013893 GM17213 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013895 GM17212 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0013921 GM17218 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013924 GM17219 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0013935 GM17140 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0013936 GM17144 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013937 GM17143 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013938 GM17142 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013939 GM17141 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013940 GM17148 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013941 GM17147 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013942 GM17146 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013943 GM17145 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0013947 GM17149 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013956 GM17150 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013960 GM17155 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013961 GM17154 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013962 GM17157 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013963 GM17156 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013964 GM17159 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013965 GM17158 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 SNP500 PANEL
CLO_0013982 GM17161 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013983 GM17162 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013984 GM17160 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013987 GM17168 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013989 GM17167 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013990 GM17166 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013993 GM17165 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013994 GM17164 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0013996 GM17163 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014022 GM17170 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014024 GM17171 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014025 GM17172 SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014026 GM17173 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014028 GM17179 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014029 GM17178 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014033 GM17175 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014034 GM17174 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014037 GM17177 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014039 GM17176 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014327 GM17239 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014330 GM17237 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014332 GM17238 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014334 GM17235 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014336 GM17236 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014338 GM17233 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014340 GM17234 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014341 GM17231 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014344 GM17232 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014347 GM17230 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014356 GM17226 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014358 GM17227 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014359 GM17228 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014362 GM17229 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014366 GM17222 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014367 GM17223 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014369 GM17224 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014371 GM17225 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014375 GM17220 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014377 GM17221 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014388 GM17259 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014389 GM17253 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014390 GM17254 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014391 GM17251 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200
CLO_0014392 GM17252 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014393 GM17257 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014394 GM17258 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014395 GM17255 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014396 GM17256 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014397 GM17250 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014404 ND02579 PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
CLO_0014408 GM17248 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014409 GM17249 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014410 GM17240 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014411 GM17241 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014412 GM17242 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014413 GM17243 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014414 GM17244 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014415 GM17245 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
CLO_0014416 GM17246 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014417 GM17247 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CLO_0014788 GM02783 ATAXIA-TELANGIECTASIA; AT
CLO_0014806 GM02767 ANEUPLOID CHROMOSOME NUMBER - TRISOMY TRISOMY 21
CLO_0014887 GM17109 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16
CLO_0014889 GM17108 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014896 GM17102 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014898 GM17103 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014900 GM17104 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014901 GM17105 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014902 GM17106 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014903 GM17107 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0014942 GM17119 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014943 GM17113 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014945 GM17114 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
CLO_0014947 GM17111 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
CLO_0014948 GM17112 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014950 GM17117 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014951 GM17118 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0014952 GM17115 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0014953 GM17116 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0014964 GM17110 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
CLO_0015081 GM17132 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015082 GM17133 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015085 GM17130 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0015087 GM17131 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0015088 GM17136 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16
CLO_0015090 GM17137 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0015093 GM17134 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015094 GM17135 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
CLO_0015097 GM17138 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015098 GM17139 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015112 GM17120 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015115 GM17121 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015117 GM17122 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015119 GM17123 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015121 GM17124 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
CLO_0015123 GM17125 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015124 GM17126 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015126 GM17127 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015128 GM17128 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
CLO_0015130 GM17129 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0015209 ND02852 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0016362 ND01737 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0016449 GM17852 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016450 GM17850 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016453 GM17845 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016454 GM17844 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016455 GM17847 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016456 GM17846 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016457 GM17842 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016458 GM17843 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016489 GM17798 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016490 GM17799 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016491 GM17800 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016492 GM17801 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016493 GM17796 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016494 GM17797 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016495 GM17802 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016496 GM17803 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016497 GM17804 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016498 GM17805 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016499 GM17811 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016500 GM17812 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016501 GM17809 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016502 GM17810 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016503 GM17807 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016504 GM17808 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016505 GM17806 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016506 GM17815 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016507 GM17813 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016508 GM17814 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016509 GM17816 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016510 GM17817 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016511 GM17818 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016515 GM17823 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016516 GM17824 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016517 GM17825 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016518 GM17826 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016519 GM17833 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016520 GM17835 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016521 GM17828 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016522 GM17831 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016523 GM17839 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016524 GM17840 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016525 GM17837 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016526 GM17838 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016527 GM17841 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016528 GM17827 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016554 GM17756 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016555 GM17755 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016558 GM17754 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016560 GM17753 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016561 GM17752 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016564 GM17749 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016565 GM17747 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016566 GM17746 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016567 GM17745 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016568 GM17744 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016593 GM17767 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016594 GM17766 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016597 GM17768 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016600 GM17762 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016601 GM17761 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0016602 GM17765 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016604 GM17764 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016606 GM17757 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0016607 GM17759 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0016608 GM17758 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016635 GM17779 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016636 GM17776 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016638 GM17775 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016641 GM17774 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016642 GM17782 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016643 GM17780 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016645 GM17773 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016646 GM17771 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016647 GM17770 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016648 GM17769 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016672 GM17792 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016675 GM17791 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016676 GM17794 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016678 GM17793 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016682 GM17795 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016684 GM17783 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016685 GM17787 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016686 GM17785 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016687 GM17790 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016688 GM17789 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0016951 GM07348 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 SNP500 PANEL HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 CEPH/UTAH PEDIGREE 1345
CLO_0016995 GM17733 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0017020 GM17741 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0017021 GM17740 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0017022 GM17739 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
CLO_0017023 GM17738 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0017024 GM17743 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0017025 GM17742 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CLO_0017043 GM17736 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0017044 GM17737 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
CLO_0017045 GM17734 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0017046 GM17735 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
CLO_0018566 ND06449 LATE ONSET PARKINSON'S DNA PANEL, AFFECTED INDIVIDUALS PARKINSON'S DISEASE
CLO_0019004 GM12264 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1375 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CLO_0020019 GM11840 CEPH/UTAH PEDIGREE 1349 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CLO_0021459 AG10941 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0021565 AG11498 LAMIN A/C; LMNA HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
CLO_0021597 AG11364 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0021875 AG10049 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0021913 AG09699 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0021943 AG09877 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022101 AG13150 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022107 AG13145 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022132 AG13066 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022320 AG14446 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022362 AG11696 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0022371 AG11726 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0022604 AG11513 LAMIN A/C; LMNA HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
CLO_0023783 GM10845 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CEPH/UTAH PEDIGREE 1424
CLO_0023784 GM10842 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CEPH/UTAH PEDIGREE 1423
CLO_0023785 GM10843 CEPH/UTAH PEDIGREE 1423 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
CLO_0023794 GM10832 SNP500 PANEL CEPH/UTAH PEDIGREE 1413
CLO_0023795 GM10833 CEPH/UTAH PEDIGREE 1413 SNP500 PANEL
CLO_0025850 GM00144 TRANSLOCATED CHROMOSOME TRISOMY 21
CLO_0026349 ND00259 POPULATION/CONVENIENCE CONTROL
CLO_0026399 ND00268 POPULATION/CONVENIENCE CONTROL
CLO_0026786 GM15386 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0026789 GM15385 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027048 ND00397 ISCHEMIC STROKE NDPT081 ISCHEMIC STROKE DNA PANEL
CLO_0027182 GM15324 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027328 GM15268 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027391 GM15245 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027447 GM15242 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027467 GM15236 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027473 GM15227 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027483 GM15223 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027484 GM15224 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027486 GM15226 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027487 GM15221 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027491 GM15216 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
CLO_0027492 GM15215 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0027493 GM15213 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0028103 GM15590 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0028397 ND01173 PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
CLO_0029036 ND06229 POPULATION/CONVENIENCE CONTROL
CLO_0029732 ND00051 POPULATION/CONVENIENCE CONTROL
CLO_0029916 GM15144 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030105 ND00022 POPULATION/CONVENIENCE CONTROL
CLO_0030305 GM15029 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
CLO_0030309 GM15038 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030311 GM15036 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030324 GM15061 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030328 GM15056 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030337 GM15072 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
CLO_0030688 ND00151 POPULATION/CONVENIENCE CONTROL
CLO_0031189 GM14381 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031198 GM14382 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031201 GM14405 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031225 GM14414 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031226 GM14409 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031227 GM14408 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031228 GM14406 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031232 AG08904 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0031234 GM14439 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031236 GM14433 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031238 GM14432 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031239 GM14417 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031253 GM14453 APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS
CLO_0031254 GM14454 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031256 GM14455 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031257 GM14440 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031260 GM14447 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031261 GM14448 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031263 GM14452 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031272 GM14475 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031274 GM14476 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031275 GM14465 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031276 GM14467 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031278 GM14464 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031280 GM14474 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031281 GM14468 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031504 GM14501 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031509 GM14503 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031510 GM14502 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031516 GM14504 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031517 GM14507 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031519 GM14506 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031529 GM14478 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031531 GM14477 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031533 GM14481 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031534 GM14480 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031535 GM14479 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031580 GM14568 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031581 GM14569 APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS
CLO_0031585 GM14581 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031600 GM14535 APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
CLO_0031601 GM14536 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031606 GM14532 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031607 GM14533 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031609 GM14509 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031610 GM14508 MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031611 GM14520 NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0031612 GM14521 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031665 GM14583 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031666 GM14582 MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CLO_0031668 GM14584 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
CLO_0031953 GM14679 NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
CLO_0032601 ND04158 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0032713 GM13649 COLORECTAL CANCER, FAMILIAL
CLO_0033199 GM13883 ATAXIA-TELANGIECTASIA; AT
CLO_0033570 AG08048 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0033577 AG08046 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0033628 GM13811 ATAXIA-TELANGIECTASIA; AT
CLO_0033747 ND04424 PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CLO_0033909 GM13995 ATAXIA-TELANGIECTASIA; AT
CLO_0034375 GM14153 ATAXIA-TELANGIECTASIA; AT
CLO_0034780 AG04147 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0034796 AG04351 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0034915 AG04655 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0035232 AG05416 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0035254 AG06237 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0035579 AG07307 BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
CLO_0035608 AG07139 GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
CLO_0036460 GM06944 TRANSLOCATED CHROMOSOME
CLO_0036870 GM07029 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1340 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
EFO_0001092 BT20 A cell line derived from epithelial cells of human breast carcinoma.
EFO_0001149 GM12750 A lymphoblastoid cell line derived from CEPH/UTAH PEDIGREE 1444.
EFO_0001168 HCC1007 A cell line derived from epithelial cells of human breast carcinoma.
EFO_0001185 HeLa A cell line derived from epithelial cells of human cervical carcinoma.
EFO_0022666 HeLa M HeLa derived cell line
EFO_0022709 BEL-7402 Human cervical adenocarcinoma cell line
EFO_0022716 WRL-68 Hela cells containing human papilloma viral (HPV) DNA sequences
EFO_0001187 HepG2 human hepatocellular carcinoma (HCC) cells (p53-wt).
EFO_0009375 184-hTERT Telomerase-immortalized human breast epithelial cell line.
EFO_0001195 IMR-32 A cell line derived from vertebrate neuroblastoma.
EFO_0001196 IMR-90 Human Fetal Lung Fibroblast cell line
EFO_0001199 LY2 A cell line derived from epithelial cells of a breast carcinoma.
EFO_0001203 MCF-7 Human breast adenocarcinoma, established from the pleural effusion of a 69-year-old caucasian woman with metastatic mammary carcinoma (after radio- and hormone therapy) in 1970; cells were described of being positive for cytoplasmic estrogen receptors and having the capability to form domes.
EFO_0001236 SKBR3 A cell line derived from epithelial cells of human breast carcinoma.
EFO_0001239 SUM1315MO2 Human SUM1315- metastatic/invasive breast ductal carcinoma cell line
EFO_0001247 T-47D cell Epithelial cells derived from human breast tumour
EFO_0001253 THP-1 A human cell line derived from peripheral blood monocytes. The patient was a 1-year-old male infant with acute monocytic leukemia.
EFO_0002059 HT-1080 cell Human with IEF of AST, LDH, NP established from the biopsy from a fibrosarcoma of a 35-year-old Caucasian man in 1972
EFO_0002067 K562 Human chronic myeloid leukemia in blast crisis established from the pleural effusion of a 53-year-old woman with chronic myeloid leukemia (CML) in blast crisis in 1970; cells can be used as highly sensitive targets in in-vitro natural killer assays; cells produce hemoglobin; cells carry the Philadelphia chromosome with a b3-a2 fusion gene.
EFO_0002069 KELLY A cell line derived from human neuroblastoma.
EFO_0002071 LNCAP Human prostate carcinoma, established from the left supraclavicular lymph node metastasis from a 50-year-old man with prostate carcinoma in 1977; cells were described to be androgen-sensitive.
EFO_0002074 PC-3 Human prostate carcinoma cell line; established from the bone marrow metastasis isolated post-mortem from a 62-year-old Caucasian man with grade IV prostate cancer, poorly differentiated adenocarcinoma, after androgen suppression therapy; described to form tumors in nude mice, to grow in soft agar, and to be unresponsive to androgen treatment.
EFO_0002075 PEL-5 PEL-5 is a human primary effusion lymphoma cell line
EFO_0002077 Ramos Ramos cell line is an EBV-negative, HLA class 1 positive B-lymphoblastoid cell line derived from a Burkitt lymphoma
EFO_0002085 T98G Human, Caucasian, glioblastoma cell line.
EFO_0002086 TIVE TIVE is a human cell line.
EFO_0002095 22Rv1 A cell line derived from human prostate carcinoma.
EFO_0002100 A101D A cell line derived from human skin melanoma.
EFO_0002113 BDCM A cell line derived from human acute myeloid leukemia.
EFO_0002117 BM1604 A cell line derived from human prostate carcinoma.
EFO_0002178 FaDu Cell line derived from squamous cell carcinoma of the hypopharynx.
EFO_0002179 G401 A human cell line derived from a pediatric patient initially classified as Wilm's tumor, reclassified as deriving from a rhabdoid tumor of the kidney.
EFO_0002180 G402 A human cell line derived from some renal leiomyeloblastoma
EFO_0002182 GCT A Giant Cell Tumor (GCT) cell line derived from a human fibrous histiocytoma lung metastasis
EFO_0002183 GDM1 A cell line derived from a human patient with Philadelphia chromosome negative myeloproliferative disorder, after transformation to acute myelomonoblastic leukemia.http://www.ncbi.nlm.nih.gov/pubmed/6296552
EFO_0002184 H4 A cell line of epithelial morphology derived from adult human brain.
EFO_0002205 Hep3B human hepatocellular carcinoma (HCC) cells (p53-null).
EFO_0002215 Jiyoye "A Jiyoye is a cell line.
A Jiyoye is bearer of a Burkitt's lymphoma."
EFO_0002225 L428 Human Hodgkin lymphoma L-428 cells
EFO_0002289 NCI-H295R Human NCI-H295R Adrenocortical Carcinoma
EFO_0002300 NCI-H69 Human Caucasian lung small cell carcinoma cell line.
EFO_0002314 RCHACV RCH-ACV cell line is a human B cell precursor leukemia cell line established from a bone marrow sample of a child with acute lymphoblastic leukemia.
EFO_0002323 RWPE1 Epithelial cells derived from the peripheral zone of a histologically normal adult human prostate were transfected with a single copy of the human papilloma virus 18 (HPV-18) to establish the RWPE-1 (ATCC CRL-11609) cell line. [PMID:9214605].
EFO_0002337 SKNEP1 SKNEP1 is a human kidney cell line derived from a patient with Nephroblastoma.
EFO_0002352 SR "Human anaplastic large T cell lymphoma cell line established from the pleural effusion an 11-year-old boy with CD30+ (Ki-1) large T cell lymphoma in 1983 (also described as ""SR""); described to express the NPM1-ALK (NPM-ALK) fusion gene (DSMZ catalog number ACC 369)"
EFO_0002360 SW1353 Human chondrosarcoma cell line
EFO_0002392 Y79 human Y79 retinoblastoma cells
EFO_0002709 BxPC-3 Human pancreatic adenocarcinoma cell line, established from a 61 year old human female.
EFO_0002711 F13 Normal pancreatic cell line
EFO_0002712 KIF5 A normal pancreas cell line.
EFO_0002713 Panc1 PANC-1 is a human pancreatic cancer cell line isolated from a pancreatic carcinoma of ductal cell origin in a 56-year-old male.
EFO_0002777 Normal Human Astrocytes NHA is a cell line derived from normal (healthy) human astrocyte cells.
EFO_0002778 BG02ES BG02ES is a cell line dervied from human embryonic stem cells.
EFO_0002782 glioblastoma H54 Glioblastoma H54 is a cell line derived from
EFO_0002783 GM06990 GM06990 is a cell line derived from some lymphoblastoid cells from a CEPH familiy of UTAH/MORMON ethnicity. It is supplied by Corriell under catalogue number GM06990.
EFO_0002786 GM12892 A cell line derived from human female B cells.
EFO_0002787 GM18507 A cell line derived from human male lymphoblasts.
EFO_0002788 GM19238 A cell line derived from human female B cells.
EFO_0002789 GM19239 A cell line derived from human male B cells.
EFO_0002790 GM19240 A cell line derived from human female B cells.
EFO_0002792 HGF A cell line derived from human normal fibroblasts.
EFO_0002793 HL-60 HL-60 is a cell line which is the bearer of human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976.
EFO_0010756 HL-60/S4 HL-60/S4 is a subline of the HL-60 cell line. The HL-60/S4 cell line was established in 1992 and is supersensitive to retinoic acid.
EFO_0002797 LHSR LHSR is a cell line in which human prostate epithelial cells (PrEC) were infected with amphotropic retroviruses encoding the SV40 large T antigen (L), the telomerase catalytic subunit hTERT (H), the SV40 small T antigen (S) and an oncogenic allele of H-ras (R) to create LHSR cells.
EFO_0002810 1205-Lu A cell line derived from human melanoma.
EFO_0002815 BJAB The malignant human B-cell-line BJAB is a EBV-negative Burkitt-like lymphoma cell line.
EFO_0002818 CADO ES1 A cell line derived from human 39 s sarcoma.
EFO_0002824 HCT116 Human colon carcinoma cell line; established from the primary colon carcinoma of an adult man.
EFO_0002827 LC-1F A cell line derived from human squamous cell lung carcinoma.
EFO_0002830 MKN1 Human gastric adenosquamous carcinoma cell line.
EFO_0002831 MKN28 Well differentiated human gastric adenocarcinoma cell line.
EFO_0002832 MKN45 Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman.
EFO_0002839 MSTO-211H Human mesothelioma cell line; established from the pleural effusion of a 62-year-old Caucasian man with mesothelioma (malignant biphasic) who did not have any prior therapy.
EFO_0002853 RM 82 A cell line derived from human 39 s sarcoma.
EFO_0002854 SBC-3 A cell line derived from human small cell lung carcinoma.
EFO_0002895 MKN7 Well differentiated human gastric adenocarcinoma cell line.
EFO_0002957 2102Ep 2102ep is an embryonal cell line
EFO_0002959 NTera2 A human embryonal carcinoma (EC) stem cell line used as a model system for the study of neuronal differentiation
EFO_0002960 BG03 A human embryonic stem cell line
EFO_0002961 NTera2 derived dopaminergic neuronal like cells A human embryonal carcinoma (EC) stem cell line used as a model system for the study of neuronal differentiation and differentiated into neuronal like cells
EFO_0003039 EAhy 926 cell The EAhy 926 cell is a hybridoma line derived from human endothelium and A549/8 cells. They display stable endothelial characteristics and may provide an indication of how endothelial cells respond to photodynamic therapy.
EFO_0003042 H1-hESC H1 human embryonic stem cell line, usually called H1-hESC and on occasion just H1
EFO_0003045 H9 "This human ES cell line expresses cell surface markers specific to undifferentiated nonhuman primate ES and human EC cells: stage-specific embryonic antigen (SSEA)–3, SSEA-4, TRA-l-60, TRA-1- 81, and alkaline phosphatase. It has a normal 46, XX karyotype. Teratomas are formed upon cell injection into SCID mice. These teratomas include cells from all three germ layers.
Isolation & Growth Conditions
This cell line can be cultured using feeder cells or in a feeder-free protocol. When using feeder cells, human ESC culture medium should be compreised of Advanced DMEM/F12 supplemented with knockout serum replacement (20%), non-essential amino acids (1x), L-glutamine (1x), penicillin/streptomycin (1x), β-mercaptoethanol (1x) and FGF-2 (4 ng/ml). Maintain the human ESCs on Matrigel using hESC medium conditioned by mouse embryonic fibroblasts."
EFO_0003056 M14 The human melanoma cell line M14 has been established from surgically removed melanoma metastases.
EFO_0004389 UCH-1 Human chordoma cell line.
EFO_0004921 GM00038 Apparently health human non-fetal tissue.
EFO_0004922 GM00719 ATAXIA-TELANGIECTASIA; AT
EFO_0005231 ECC-1 An established epithelial cell line derived from an adenocarcinoma of human endometrial lining.
EFO_0005234 PFSK-1 Neuroectodermal cell line derived from a cerebral brain tumor.
EFO_0005236 NT2/D1 The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. Derived from metastatic site: lung
EFO_0005237 U-87 MG A human epithelial cell derived from subject with grade IV glioblastoma; astrocytoma.
EFO_0005263 TOV-112D TOV-112D is a human epithelial cell line initiated in October of 1992 from a patient with early onset ovarian cancer. The patient was of French-Canadian descent with an unknown family history of ovarian cancer.
EFO_0005264 Ect1 The ectocervical Ect1/E6E7 (ATCC CRL-2614) and endocervical End1/E6E7 (ATCC CRL-2615) cell lines were established in 1996 from normal epithelial tissue taken from a premenopausal woman undergoing hysterectomy for endometriosis.
EFO_0005265 MOLT-3 MOLT-3 is a male human malignant T-lymphoblastic cell line.
EFO_0005282 HS-5 Established from human bone marrow stromal cells transformed by HPV-16 E6/E7.
EFO_0005283 HS-27A Established from human bone marrow stromal cells transformed by HPV-16 E6/E7.
EFO_0005355 HUES1 A human embryonic stem cell line
EFO_0005384 HuH-7 HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers.
EFO_0005388 JIMT-1 "Source : Pleural effusion, Ductal breast cancer (grade 3 invasive, T2N1M0)
Karyotype : Highly rearranged hyperdiploid karyotype with 6% polyploidy
Carry an amplified HER-2 oncogene and to be insensitive to HER-2-inhibiting drugs"
EFO_0005441 DU 145 A cell line derived from human prostate carcinoma. The patient was a 69-year-old male, and the sample was derived from brain metastasis.
EFO_0005445 PEO1 PEO1 is an adherent cell line derived from a malignant effusion from the peritoneal ascites of a patient with a poorly differentiated serous adenocarcinoma. The patient previously received cisplatin, 5-fluorouracil and chlorambucil treatment. PEO1 is tumourigenic in immunologically-deprived CBA mice. PEO1 exhibits good growth in semi-solid medium (agar). PEO1 is from the same patient as the PEO4 and PEO6 cell lines (Sigma Catalogue numbers 10032309 & 10032310).This cell line is one of nine from the PE ovarian adenocarcinoma panel (derived from 4 patients at varying stages of ovarian cancer, isolated from various malignant sites, and at various treatment stages) available at ECACC which provides a model system for research into the mechanism of oestrogen action on ovarian adenocarcinoma tumour cells, and for the study of efficacy and toxicity of oestrogen protagonists. (Sigma-Aldrich catalog number 10032308)
EFO_0005696 D721Med Medulloblastoma (aka D721), surgical resection from a patient with medulloblastoma as described by Darrell Bigner (1997)
EFO_0005697 M059J M059J cells were isolated from a tumor specimen taken from a 33 year old male with untreated malignant glioblastoma. The cells were isolated concurrently from the same tumor specimen as M059K (see CRL-2365).
EFO_0005698 Daoy The Daoy cell line was established in 1985 by P. F Jacobsen of the Royal Perth Hospital in Western Australia. The line was derived from biopsy material taken from a tumor in the posterior fossa of a 4 year old boy.
EFO_0005700 TTC549 This is an adherent cell line derived from a hepatic rhabdoid tumor. Hepatic rhabdoid tumors are extremely rare. This cell line has a large deletion on 22q, which indicates numerous genes in addition to SNF5 are deleted.
EFO_0005702 A204.1 A malignant rhabdoid tumor diploid cell population cloned from the A204 ATCC cell line. [PMID: 16897758]
EFO_0005703 G401.6 This is an adherent cell line that represents the prototypical renal rhabdoid tumor [PMID: 16897758]. G401.6 is a diploid, 6-thioguanine-resistant clonal variant of the G401 cell line isolated by Weissman et al., Science, 236:175-180 (1986). The parental cell line, G401, can be ordered from the ATCC (CRL1441).
EFO_0005704 HuH-7.5 HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers. HuH7.5 developed from HuH7.
EFO_0005705 olfactory neurosphere cell line Nasal biopsies were collected from volunteer donors as an outpatient procedure as described (Feron et al., 1998). This was done by a registered otolaryngologist via an endoscopic procedure to ensure biopsy samples were taken from the superior, posterior region of the nasal septum close to the cribriform plate. Pieces of olfactory mucosa were obtained which contain stem cells in the olfactory epithelium. The stem cell population derived from human olfactory mucosa has been described as ecto-mesenchymal (Delorme et al., 2010) because it has characteristics of both neural and mesenchymal stem cells, suggesting a neural crest origin.
EFO_0009494 C1 100080002 Cell line from olfactory neurosphere cells from a 59-year-old human male.
EFO_0009495 C1 100080003 Cell line from olfactory neurosphere cells from a 66-year-old human female.
EFO_0009496 C1 100080013 Cell line from olfactory neurosphere cells from a 64-year-old human male.
EFO_0005706 Mel-2183 " in the Surgery Branch of the NCI."">This cell line was from a melanoma metastasis tumor taken from the subcutaneous shoulder of an individual. Cell line was derived by Dr. Yardena Samuels (samuelsy[at]mail.nih.gov)"
EFO_0005707 786-0 This line was derived from a primary clear cell adenocarcinoma. The karyotype is hypertriploid; Y was present in 60% the cells examined. The cells display both microvilli and desmosomes, and can be grown in soft agar. The cells produce a PTH like peptides that is identical to peptides produced by breast and lung tumors.
EFO_0005709 HTR8/SVneo First trimester human trophoblast cells established by immortalizing a physiologic extravillous trophoblast cell via transfection with a plasmid containing the simian virus 40 large T antigen (SV40) (see Graham et al., 1993). Cells are a thin layer of ectoderm that forms the wall of many mammalian blastulas and functions in the nutrition and implantation of the embryo.
EFO_0005710 HFF-Myc This is an adherent cell line. HFF-Myc are human foreskin fibroblasts containing a virally integrated vector expressing the canine cMyc gene. Cells were received from Dr. Beverly Torok-Storb, Fred Hutchison Cancer Research Center, Seattle, WA.
EFO_0005711 HPDE6-E6E7 Normal benign adult human pancreatic duct cells immortalized with E6E7 gene of HPV-16. HPDE6-E6E7 cells demonstrated a near normal genotype and phenotype of pancreatic duct epithelial cells. [PMC1861644]
EFO_0005712 RPMI-7951 Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node.
EFO_0005713 8988T "Human pancreas adenocarcinoma (PA-TU-8988T), ""established in 1985 from the liver metastasis of a primary pancreatic adenocarcinoma from a 64-year-old woman; sister cell line of PA-TU-8988S"" - DSMZ."
EFO_0005714 LHCN-M2 "Skeletal myoblasts derived from satellite cells from the pectoralis major muscle of a 41 year old caucasian heart transplant donor, immortalized with lox-hygro-hTERT (LH), and Cdk4-neo (CN), Zhu et al. (2007) in Aging Cell, vol. 6, pp 515-523. M2 is an extremely well-differentiating subclone of LHCN (thus ""LHCN-M2"")."
EFO_0005715 WERI-Rb-1 The WERI-Rb-1 line is one of two human retinoblastoma cell lines established in 1974 by R.M. McFall and T.W. Sery. This is a near diploid line. The modal chromosome number is 47 occurring at 38%, and the rate of polyploidy is 9%. Cells are grape-like clusters of round cells in suspension.
EFO_0005718 Ishikawa """The cell line Ishikawa was established from an endometrial adenocarcinoma of a 39 year old woman. Cells can be commercially obtained from Sigma (99040201-1VL). However, it should be noted that the original source of these cells (M. Nashide, Japan) can spontaneously lose the progesterone and
estrogen receptor. For details, see Nishida M., The Ishikawa cells from birth to the
present. Hum Cell. 2002 Sep;15(3):104-17."""
EFO_0005720 SK-MEL-5 This melanoma cell line was derived from a metastatic axillary node of the skin of a 24 year old female. It is a hyperpentaploid human cell line with the modal chromosome number of 120, occurring in 9% of cells. [PMID: 1067619]
EFO_0005721 SK-N-DZ SK-N-DZ is a neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a child with poorly differentiated embryonal neuroblastoma.
EFO_0005722 SJRH30 The line was established from cells from the bone marrow of a child with rhabdomyosarcoma. Derived from a metastatic site of the bone marrow. The cells show ultrastructural elements of primitive skeletal muscle differentiation.
EFO_0005723 GM23248 Fibroblasts taken from a skin punch of the arm
EFO_0005724 MM.1S MM.1S is a B lymphoblast cell line derived in 1986. The parent cell line, MM.1, was established from peripheral blood of a multiple myeloma patient who had become resistant to steroid-based therapy. provide critical information about disease progression and the development of drug resistance. This cell line represents a valuable tool for elucidating the mechanisms of action of glucocorticoids and the development of new therapeutics. [PMID: 2926241]
EFO_0005725 BE(2)-C BE(2)-C is a clone of the SK-N-BE(2) neuroblastoma cell line (ATCC CRL-2271) that was established in November of 1972 from a bone marrow biopsy taken from child with disseminated neuroblastoma after repeated courses of chemotherapy and radiotherapy. The cells grow as clusters of flattened neuroblastic cells with occasional fine cell processes (neurites). Unlike the parent line, they generally do not detach and float.
EFO_0005726 LNCaP clone FGC LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old Caucasian male (blood type B+) with confirmed diagnosis of metastatic prostate carcinoma. This is a hypotetraploid human cell line. The modal chromosome number was 84, occurring in 22% of cells. However, cells with chromosome counts of 86 (20%) and 87 (18%) also occurred at high frequencies. These cells are responsive to 5-alpha-dihydrotestosterone (growth modulation and acid phosphatase production).
EFO_0005901 ELF-1 Human embryonic stem cell line ELF-1 was derived from a human embryo in the Ellison Stem Cell Core at the University of Washington, Seattle, WA.
EFO_0005903 KBM-7 KBM-7 cells were derived from a 39-year-old man with chronic myeloid leukemia in blast crisis. The original cell line contained both near haploid and hyperdiploid clones. Subsequent subcloning yielded a pure near-haploid cell line.Genome analysis has revealed that besides the disomic chromosome 8 also a 30 megabase fragment of chromosome 15 is present in two copies. Like other CML cells lines (e.g., K562) KBM-7 cells are positive for the Philadelphia chromosome harboring the BCR-ABL oncogenic fusion. KBM-7 cells have been reprogrammed to yield the HAP1 cell line which is also haploid for chromosome 8.
EFO_0007598 HAP-1 HAP1 is a near-haploid human cell line that was derived from the male chronic myelogenous leukemia (CML) cell line KBM-7. HAP1 cells are adherent with fibroblast-like morphology.
EFO_0005904 H7-hESC Undifferentiated embryonic stem cells
EFO_0005907 OCI-LY1 Established from the bone marrow of a 44-year-old man with B-cell Non-Hodgkin lymphoma (B-NHL; diffuse large cell), stage 4B at relapse in 1983.
EFO_0005909 HGADFN167 Dermal fibroblasts from an 8 year old male with Hutchinson-Gilford progeria syndrome (cell line HGPS, HGADFN167, progeria research foundation).
EFO_0005912 hTERT-HM An immortalized cell line from hTERT-infected myometrial cells (hTERT-HM). Cells were isolated from myometrial tissue obtained from women undergoing hysterectomy, and retroviral infection was used to express the catalytic subunit of telomerase in myometrial cells.
EFO_0005913 urothelium cell line Primary ureter cell culture of urothelial cells derived from a 12 year-old girl and immortalized by transfection with a temperature-sensitive SV-40 large T antigen gene.
EFO_0006268 A431 The epidermoid carcinoma cell line A-431, derived from an 85-year-old female, is one of a series of cell lines established from solid tumors by D.J. Giard, et al. This is a hypertriploid human cell line. The modal chromosome number was 74 occurring in 36% of cells. The rate of cells with higher ploidies was 1.0%.
EFO_0006269 ACH-3P Cell line was established by fusion of primary human first trimester trophoblasts (week 12 of gestation) with a human choriocarcinoma cell line (AC1-1).
EFO_0006270 AG04450 The culture was initiated on 5/20/80 from explants of minced lung tissue taken from a therapeutically aborted fetus of 12 weeks gestational age. The cell morphology is fibroblast-like. The karyotype is 46,XY; normal diploid male. A matched skin-derived fibroblast culture from same fetus is AG04449.
EFO_0006271 ARPE-19 ARPE-19 is a spontaneously arising retinal pigment epithelia (RPE) cell line derived in 1986 by Amy Aotaki-Keen from the normal eyes of a 19-year-old male who died from head trauma in a motor vehicle accident.
EFO_0006276 GM15850 Clinically affected; ataxia; scoliosis; hypertrophic cardiomyopathy; slurred speech; homozygous for the GAA expansion in the frataxin gene with alleles of approximately 650 and 1030 repeats; brother of GM15849 and GM15851, son of GM15847 and GM15848.
EFO_0006277 GM15851 Clinically unaffected;has two FRDA alleles in the normal range of GAA trinucleotide repeats;brother of an affected individual (GM15850).
EFO_0006278 GM5659 GM5659 primary fibroblasts were established from a skin biopsy of an apparently healthy donor
EFO_0006279 HPAF1 Cell line is derived from the normal human parotid gland. The cell lines are propagated in serum-free medium comprised of keratinocyte basal medium supplemented with insulin (5 micrograms/ml), hydrocortisone (0.5 micrograms/ml),epidermal growth factor (EGF, 10 ng/ml), bovine pituitary extract (25 micrograms/ml), and antibiotics. Normal diploid karyotypes, lack transformed phenotypes and non-tumorigenic in nude mice. Produces tissue-specific proteins, i.e. α-amylase 1, basic proline-rich protein, and cystatins; and expressed the corresponding genes as determined by RT-PCR analyses.
EFO_0006280 HPAM1 Cell line is derived from the normal human parotid gland. The cell lines are propagated in serum-free medium comprised of keratinocyte basal medium supplemented with insulin (5 micrograms/ml), hydrocortisone (0.5 micrograms/ml),epidermal growth factor (EGF, 10 ng/ml), bovine pituitary extract (25 micrograms/ml), and antibiotics. Normal diploid karyotypes, lack transformed phenotypes and non-tumorigenic in nude mice. Produces tissue-specific proteins, i.e. α-amylase 1, basic proline-rich protein, and cystatins; and expressed the corresponding genes as determined by RT-PCR analyses.
EFO_0006281 JinB8 CD47-deficient T cell line derived from Jurkat cells (JinB8)
EFO_0006282 KM12 KM12 is one of the cell lines of the NCI-60 panel which represents different cancer types and has been widely utilized for drug screening and molecular target identification.
EFO_0006285 MEC2 Cell line grew spontaneously on two subsequent occasions from the peripheral blood (PB) of a patient with B-chronic lymphocytic leukemia (B-CLL) in prolymphocytoid transformation. The patient was EBV-seropositive, his leukemic cells were EBNA negative, but the spontaneously grown cell lines are EBNA-2 positive. MEC2 cells do not adhere and form large clumps. The doubling time of MEC2 is 31h.
EFO_0006287 Mono Mac 6 A monocytic cell line, termed Mono Mac, was established from peripheral blood of a patient with monoblastic leukemia. Two clones, designated Mono Mac I and Mono Mac 6, were isolated and both were assigned to the monocyte lineage on the basis of morphological, cytochemical and immunological criteria. Most importantly, the clones express NaF-sensitive non-specific-esterase, produce reactive oxygen and stain with MAb My4. Mono Mac 6, in addition, constitutively exhibits phagocytosis of antibody-coated erythrocytes in 80% of the cells and reacts with a panel of MAbs that are specific for mature monocytes, i.e., M42, LeuM3, 63D3, Mo2 and UCHMI. By contrast, the monoblastic cell lines U937 and THP-I are negative for all these markers. Only expression of My4 could be detected after differentiation induced by interferon-gamma (IFN-gamma). Similar treatment of Mono Mac I, however, resulted in staining with all the monocyte-specific MAbs mentioned above, while IFN-gamma treatment of Mono Mac 6 enhanced antigen expression. In addition, the cells showed an increased frequency of multinucleated cells with a rise from 4.8% to 21.9%. Mono Mac 6 appears to be the only one of the cell lines studied to constitutively express phenotypic and functional features of mature monocytes.
EFO_0006294 SHEP SH-EP is derived from SK-N-SH cell line. Cells of SH-EP are flattened in shape and do not have neuritic processes.
EFO_0006296 STS26T STS26T cells were derived from a sporadic MPNST and have functional neurofibromin
EFO_0006304 T265 The T265 cell line is widely used for cell culture studies of Schwann cells in MPNSTs. This cell line has characteristics consistent with Schwann cells that have been transformed into a malignant phenotype because of the loss of neurofibromin in the auto-somal-dominant condition NF1
EFO_0006354 105KC Human chondrosarcoma cell line.
EFO_0006355 143B Human osteosarcoma cell line. ATCC catalog number CRL-8308
EFO_0006358 59M Human ovarian carcinoma cell line. (Sigma-Aldrich catalog number 89081802)
EFO_0006362 A2780 Human ovarian carcinoma cell line. (Sigma-Aldrich catalog number 93112519)
EFO_0006364 C32 Human melanoma cell line. ATCC catalog number CRL-1585
EFO_0006365 C4-2B Human prostate cancer cell line derived from subcutaneous LNCaP xenografts in castrated nude mice.
EFO_0006366 CAL 27 Human squamous cell carcinoma cell line
EFO_0006373 COLO 680N Human squamous cell carcinoma cell line (DSMZ catalog number ACC 182)
EFO_0006376 COLO 783 Human melanoma cell line (DSMZ catalog number ACC257)
EFO_0006377 COLO 792 Derived from a brain metastasis of a 62 year old male with melanoma. The cells bleb during culture. (Sigma-Aldrich catalog number 93052616)
EFO_0006378 COLO 800 Derived from a subcutaneous nodule of a tumour from a 14-year-old male. Cells display remarkable blebbing. (Sigma-Aldrich catalog number 93051123)
EFO_0006379 COLO 849 derived in 1992 from right axillary lymph nodes of a 43-year-old Caucasian man with metastatic maligant melanoma (DSMZ catalog number ACC 216)
EFO_0006380 COLO 853 Derived from the right axilla lymph node of a 43 year old male with melanoma. (Sigma-Aldrich catalog number 93052606)
EFO_0006381 COLO 857 Derived from a right axilla lymph node of a 43 year old male with melanoma. The biopsy material was obtained post chemotherapy. (Sigma-Aldrich catalog number 93051120)
EFO_0006382 COV318 A human ovarian epithelial-serous carcinoma cell line established from a peritoneal ascites. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071903)
EFO_0006383 COV362 A human ovarian epithelial-endometroid carcinoma cell line established from a pleural effusion. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071910)
EFO_0006384 COV434 Human ovarian granulosa tumour cell line established from a solid primary tumour (Sigma-Aldrich catalog number 07071909)
EFO_0006385 COV504 A human ovarian epithelial-serous carcinoma cell line established from a pleural effusion. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071902)
EFO_0006386 COV644 Human ovarian epithelial-mucinous carcinoma cell line established from a solid primary tumour. Anchorage-independent growth in agar has been reported. (Sigma-Aldrich catalog number 07071908)
EFO_0006389 DLD1 Dukes' Type C, Colorectal Adenocarcinoma cell line. ATCC catalog number CCL-221
EFO_0006390 DMS 454 The small cell carcinoma DMS 454 was isolated in 1981 from lung tissue of a male patient at time of autopsy. (Sigma-Aldrich catalog number 95062832)
EFO_0006393 Farage The Farage cell line was adapted to culture in 1990 from a lymph node biopsy of a patient with diffuse large cell non-Hodgkin's lymphoma (DLCL). (ATCC catalog number CRL-2630)
EFO_0006394 G-361 Human malignant melanoma cell line (ATCC catalog number CRL-1424)
EFO_0006395 G111 Human glioma cell line
EFO_0006396 G112 Human glioma cell line
EFO_0006397 G118 Human glioma cell line
EFO_0006398 G120 Human glioma cell line
EFO_0006399 G121 Human glioma cell line
EFO_0006400 G122 Human glioma cell line
EFO_0006401 G124 Human glioma cell line
EFO_0006402 G130 Human glioma cell line
EFO_0006403 G140 Human glioma cell line
EFO_0006404 G141 Human glioma cell line
EFO_0006405 G142 Human glioma cell line
EFO_0006406 G22 Human glioma cell line
EFO_0006407 G28T Human glioma cell line
EFO_0006408 G44 Human glioma cell line
EFO_0006409 G59 Human glioma cell line
EFO_0006410 G61 Human glioma cell line
EFO_0006411 G84 Human glioma cell line
EFO_0006412 G96 Human glioma cell line
EFO_0006415 HCA-7 The human colon cancer cell line, HCA-7 Colony 29 expresses Cox-2. An interesting feature of this cell line is that it forms polarised epithelial sheets which allows examination of the trafficking and release of biomolecules in vitro. Cyclooxygenases (COXs) are key enzymes in the conversion of arachidonic acid to prostaglandins and other eicosanoids. It has been found that colonic polyps and cancers overexpress Cox-2 and that the inhibition of this enzyme by nonsteroidal anti-inflammatory drugs decreases the risk of colonic neoplasia. This cell line is useful for studying the role of Cox-2 in cancer cell biology and the investigation of colorectal epithelial cell polarity. Imperial College Innovations has stated that this cell line is not to be supplied to commercial organisations. (Sigma-Aldrich catalog number 02091238)
EFO_0006431 HCC2279 Human lung adenocarcinoma cell line from 52-year-old Asian female patient
EFO_0006438 HEp-2 Cells of this line contain HeLa marker chromosomes, and were derived via HeLa contamination. This line was originally thought to be derived from an epidermoid carcinoma of the larynx, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via HeLa cell contamination. The cells are positive for keratin by immunoperoxidase staining. ATCC confirmed this cell line is positive for the presence of human papilloma viral DNA sequences via PCR.
EFO_0006439 HOP62 Human non small cell lung carcinoma cell line
EFO_0006441 Hs 683 Human glioma cell line (ATCC catalog number HTB-138)
EFO_0006442 HT115 Human colon carcinoma cell line. Cells possess Ca antigen as defined by the Ca1 antibody. The Ca antigen has been shown to be absent in non-malignant human cell strains and is considered to be a marker linked with malignancy. Island cell growth will degenerate if left more than 9 days between passages. (Sigma-Aldrich catalog number 85061104)
EFO_0006443 HT144 Human malignant melanoma cell line derived from metastatis in subcutaneous tissue from a 29-year-old male Caucasian patient. (ATCC catalog number HTB-63)
EFO_0006444 HT55 Human colon carcinoma cell line (Sigma-Aldrich catalog number 85061105)
EFO_0006446 IM-95 Human adenocarcinoma cell line from a 63-year-old Japanese male patient with moderately differentiated adenocarcinoma of the stomach
EFO_0006448 JL-1 Human malignant epithelioid mesothelioma cell line established from the untreated malignant epithelioid mesothelioma of the pleura of a 54-year-old man with asbestos cancer in 2003 (DSMZ catalog number ACC 596)
EFO_0006451 M059K M059K cells were isolated from a tumor specimen from a 33 year-old male patient with untreated glioblastoma. (ATCC catalog number CRL-2365)
EFO_0006454 MDA-MB-330 Human breast carcinoma cell line (ATCC catalog number HTB-127)
EFO_0006456 MS751 Human cervical epidermoid carcinoma cell line derived from metastatis in lymph node (ATCC catalog number HTB-34)
EFO_0006458 OV56 The OV56 cell line was established from ascitic fluid derived from a 46-year-old female patient diagnosed with ovarian cancer. The tumour was characterised as stage IV, poorly differentiated. Immunocytochemical staining of the cells was reported to show strong staining for cytokeratin (CK), weak staining for carcinoembryonic antigen (CEA) and strong staining for human milk fat globulin (HMFG-2). Production of vascular endothelial growth factor (VEGF) has been detected by ELISA. The patient had received sequential treatment with cisplatin and cyclophosphamide, cisplatin and etoposide and subsequently tamoxifen. (Sigma-Aldrich catalog number 96020759)
EFO_0006459 OV7 The OV7 cell line was established from solid ovarian tumour tissue taken from a 78-year-old female patient. The tumour was characterised as stage III, mixed tumour type and poorly differentiated. Immunocytochemical staining of the cells was reported to show strong staining for cytokeratin (CK), no staining for carcinoembryonic antigen (CEA) and strong staining for human milk fat globulin (HMFG-2). Detection of mRNA expression of vascular endothelial growth factor (VEGF) and its receptors flt and KDR has been reported. The patient had received treatment with chlorambucil. (Sigma-Aldrich catalog number 96020764)
EFO_0006465 PA-1 Human ovarian teratocarcinoma cell line derived from metastasis in ascites (ATCC catalog number CRL-1572)
EFO_0006466 Panc 02.03 Panc 02.03 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma. (ATCC catalog number CRL-2553)
EFO_0006467 Panc 03.27 Panc 03.27 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma. (ATCC catalog number CRL-2549)
EFO_0006468 Panc 04.03 Panc 04.03 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a male with pancreatic adenocarcinoma. (ATCC catalog number CRL-2555)
EFO_0006469 Panc 05.04 Panc 05.04 is a pancreatic adenocarcinoma epithelial cell line derived, in 1995, from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma. (ATCC catalog number CRL-2557)
EFO_0006470 Panc 08.13 Panc 08.13 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a male with pancreatic adenocarcinoma. (ATCC catalog number CRL-2551)
EFO_0006472 Pfeiffer The Pfeiffer cell line was established in 1992 from a patient in the leukemic phase of diffuse large cell lymphoma (DLCL) with cleaved and non-cleaved nuclei. (ATCC catalog number CRL-2632)
EFO_0006474 PL45 PL45 is a pancreatic adenocarcinoma epithelial cell line derived in 1992 from a primary tumor removed from the pancreas of a man with poorly differentiated pancreatic adenocarcinoma of ductal origin. (ATCC catalog number CRL-2558)
EFO_0006476 RCM-1 Human colorectal adenocarcinoma cell line
EFO_0006478 RPMI 2650 Human squamous cell carcinoma derived from metastatis in pleural effusion (ATCC catalog number CCL-30)
EFO_0006479 RT-112 Human carcinoma cell line established from the transitional cell carcinoma (histological grade G2) excised from a woman (age unknown) with untreated primary urinary bladder carcinoma in 1973; described to form tumors in nude mice (DSMZ catalog number ACC 418)
EFO_0006480 RT4 Human transitional cell papilloma cell line (ATCC catalog number HTB-2)
EFO_0006481 SC-1 Human B-cell lymphoma cell line from a 67-year-old male patient
EFO_0006490 SK23 Human melanoma cell line
EFO_0006492 SU-DHL-4 Human lymphoma cell line isolated from peritoneal effusion in a 38-year-old male Caucasian patient. (ATCC catalog number CRL-2957)
EFO_0006493 SU-DHL-8 Human large cell lymphoma cel line derived from peritoneal effusion in a 59-year-old male Caucasian patient (ATCC catalog number CRL-2961).
EFO_0006494 SU.86.86 Human pancreatic ductal carcinoma derived from metastasis in liver. (ATCC catalog number CRL-1837)
EFO_0006496 TMD8 Human diffuse large B cell lymphoma cell line derived from a 62-year-old male patient.
EFO_0006498 U-251 MG Human glioblastoma cell line (Sigma-Aldrich catalog number 09063001)
EFO_0006499 U-2932 Human diffuse large B cell lymphoma cell line established in 1996 from the ascites of a 29-year-old woman with diffuse large B cell lymphoma, who 16 years earlier was diagnosed with advanced stage Hodgkin lymphoma, and relapsed several times after multiple chemo- and radiotharapy regimens to complete remissions; cells were described to overexpress BCL2, BCL6 and p53; assigned to ABC-like lymphoma subtype (activated B-cell) (DSMZ catalog number ACC 633)
EFO_0006528 23132/87 human gastric adenocarcinoma cell line established from the primary tumor of a 72-year-old man with gastric adenocarcinoma in 1987 confirmed as human with IEF of AST, MDH
EFO_0006531 888-mel human melanoma cell line designated 888-mel has been developed from the resected tumor of a 26-year old Caucasian female (patient 888) diagnosed with metastatic melanoma - See more at: https://ttc.nci.nih.gov/opportunities/opportunity.php?opp_id=34826089312#sthash.to7UCByK.dpuf
EFO_0006532 A3/KAW human lymphoma cell line from a 68 year old female Japanese patient with stomach cancer and lymphoma
EFO_0006533 A4/Fuk human lymphoma cell line from a 52 year old female Japanese patient with malignant melanoma
EFO_0006534 AMO-1 human plasmacytoma cell line from a 64 year old female patient (DSMZ catalog number ACC 583)
EFO_0006535 ATRFLOX human colorectal carcinoma cell line from an adult male patient (ATCC CRL-2780)
EFO_0006537 BEN human carcinoma cell line established from the supraclavicular tumor cells-containing lymph node of a 71-year-old man with poorly differentiated carcinoma of the lung (DSMZ calatog number: ACC 254)
EFO_0006538 BFTC-909 human cell carcinoma established from the sarcomatoid component of a grade III transitional cell carcinoma of the renal pelvis of a 64-year-old man in 1990; patient lived in a blackfoot disease endemic area in Taiwan (DSMZ catalog number ACC 367)
EFO_0006539 BHY human oral squamous cell carcinoma established from the tumor of a 52-year-old Japanese man with highly differentiated squamous cell carcinoma of the lower alveolus which was highly invasive to the mandibular bone and the muscle layer of the oral floor (DSMZ catalog number ACC 404)
EFO_0006540 BICR 10 human recurrent squamous cell carcinoma of the buccal mucosa of a Caucasian female (Sigma catalog number 04072103)
EFO_0006541 BICR 22 human cell line derived from a lymph node metastasis squamous cell carcinoma of the tongue of a Caucasian male (Sigma catalog number 04072106)
EFO_0006542 BICR 31 human cell line derived from a lymph node metastasis squamous cell carcinoma of the tongue of a Caucasian male (Sigma catalog number 04072107)
EFO_0006543 BICR 78 human cell line derived from a squamous cell carcinoma of the oral alveolus of a Caucasian male (Sigma catalog number 04072111)
EFO_0006546 C2BBe1 human colorectal carcinoma cell line from a 72 year old male patient (ATCC CRL-2102)
EFO_0006547 CAL-12T human cell lung carcinoma line established from a male patient with a non-small cell lung carcinoma in 1981 (DSMZ catalog number ACC 443)
EFO_0006548 CaR-1 human rectal carcinoma cell line establish from a metastatic lymph node of a 70-year-old male patient with primary rectal adenocarcinoma
EFO_0006549 CaSki human cervical epidermoid carcinoma cell line from a 40 year old female Caucasian patient (ATCC CRL-1550)
EFO_0006550 CCRF-SB human lymphoma cell line from a 11.5 year old male Caucasian patient (ATCC CCL-120)
EFO_0006551 CFPAC-1 human ductal pancreatic adenocarcinoma derived by differential trypsinisation of explant cultures from a metastatic lesion in the liver of a 26 year old caucasian male with cystic fibrosis (Sigma catalog number 91112501)
EFO_0006552 CMA-03 human myeloma cell line derived from a peritoneal effusion of a patient with refractory myeloma
EFO_0006553 CMA-03/06 human myeloma cell line derived from CMA03
EFO_0006554 COLO 206F human colon adenocarcinoma cell line established from the ascites fluid obtained from a 70-year-old male patient with adenocarcinoma of the colon (Sigma catalog number 93052620)
EFO_0006555 COR-L26 human large cell lung cancer bone marrow aspirate derived cell line established from a female patient (Sigma catalog number 96020740)
EFO_0006556 COR-L47 human lung cancer cell line derived from the bone marrow aspirate of a 67-year-old Caucasian male suffering from small cell lung carcinoma (Sigma catalog number 92031915)
EFO_0006557 COV413A human ovarian epithelial-serous carcinoma cell line established from a metastasis of the sigmoid colon (Sigma catalog number 07071905)
EFO_0006558 COV413B human ovarian epithelial-serous carcinoma cell line established from an intraperitoneal metastasis of the bladder dome (Sigma catalog number 07071906)
EFO_0006559 CPC-N human small lung carcinoma cell line established from the pleural effusion metastasis of a patient with small cell lung carcinoma in 1987 (DSMZ catalog number ACC 306)
EFO_0006560 CW-2 human colon carcinoma cell line
EFO_0006561 CX-1 human colon adenocarcinoma cell line established from the tumor tissue of a 44-year-old woman with well-differentiated colon adenocarcinoma in 1984 (DSMZ catalog number ACC 129)
EFO_0006562 DAN-G human pancreas carcinoma cell line established from a human individual with pancreas carcinoma in 1985 (DSMZ catalog number ACC 249)
EFO_0006563 DEOC-1 human malignant melanoma cell line established from the heel lesion of a 59-year-old Japanese man
EFO_0006564 DOK human dysplastic oral keratinocyte cell line isolated from a piece of dorsal tongue from a 57 year old Caucasian man (Sigma catalog number 94122104)
EFO_0006565 DV-90 human lung adenocarcinoma established from the pleural effusion of a stage IV lung adenocarcinoma
EFO_0006568 EFM-192A human breast carcinoma cell line established from the pleural effusion of the left side (14 days after EFM-192A) of a 46-year-old Caucasian woman with breast adenocarcinoma (DSMZ catalog number ACC 311)
EFO_0006569 EFM-192B human breast carcinoma cell line established from the pleural effusion of the left side (14 days after EFM-192A) of a 46-year-old Caucasian woman with breast adenocarcinoma (DSMZ catalog number ACC 308)
EFO_0006570 EFM-192C human breast carcinoma cell line human breast carcinoma cell line established from the pleural effusion of the left side from a 46-year-old Caucasian woman with metastasizing breast adenocarcinoma in 1985 (DSMZ catalog number ACC 258)
EFO_0006571 EFO-27 human ovarian adenocarcinoma cell line established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979 (DSMZ catalog number ACC 191)
EFO_0006572 EJM human multiple myeloma cell line established from the peritoneal fluid of a 58-year-old woman with IgG lambda myeloma in 1988 at her terminal refractory stage (DSMZ catalog number ACC 560)
EFO_0006573 EPLC-272H human lung adenocarcinoma cell line established from a surgical lung specimen of a 57-year-old Caucasian man who underwent surgery for undifferentiated squamous cell carcinoma of the lung (without having received prior radiation or chemotherapy) in 1986 (DSMZ catalog number ACC 383)
EFO_0006574 EVSA-T human breast carcinoma cell line established from the malignant ascitic effusion from a woman with metastatic breast carcinoma; described as being estrogen receptor-negative and progesterone receptor-positive (DSMZ catalog number ACC 433)
EFO_0006575 GP2d human colon adenocarcinoma cell line derived from a local recurrence of Duke′s grade B, poorly differentiated carcinoma of the colon from a 71 year old female at surgical resection (SIgma catalog number 95090714)
EFO_0006576 GP5d human colon adenocarcinoma cell line derived from a local recurrence of Duke′s grade B, poorly differentiated carcinoma of the colon from a 71 year old female at surgical resection (SIgma catalog number 95090715)
EFO_0006577 GR-M human melanoma obtained from the thorax of a 36 year old male with skin metastases having received no treatment at the time of the biopsy (Sigma catalog number 95032301)
EFO_0006578 GTL-16 human gastric carcinoma cell line with amplification of the MET oncogene (Motoyama et al., 1986)
EFO_0006579 HEL Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis
EFO_0006580 HEY human ovarian carcinoma cell line was derived from a human ovarian cancer xenograft (HX-62) originally grown from a peritoneal deposit of a patient with moderately differentiated papillary cystadenocarcinoma of the ovary (catalog number AKR-205)
EFO_0006581 HGC-27 human gastric carcinoma cell line established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histologically as undifferentiated carcinoma
EFO_0006582 HMY-1 human melanoma cell line established from metastasised lymph node of a 62 year old Japanese man
EFO_0006583 HNT-34 human acute myeloid leukemia cell line established in 1994 from the peripheral blood of a 47-year-old woman with acute myeloid leukemia (AML FAB M4) secondary to previous myelodysplastic syndromes (MDS), specifically chronic myelomonocytic leukemia (CMML) (DSMZ catalog number ACC-600)
EFO_0006584 Hs 255.T human colon adenocarcinoma cell line from a 46 year old Caucasian woman (ATCC CRL-7213)
EFO_0006585 Hs 294T human melanoma cell line from a 56 year old Caucasian male (ATCC HTB-140)
EFO_0006586 Hs 38.T human ovarian teratoma cell line from a female (ATCC CRL-7826)
EFO_0006587 Hs 675.T human colorectal cancer cell line from a Caucasian male (ATCC CRL-7400)
EFO_0006588 Hs 695T human melanoma cell line from a 26 year old Caucasian male (ATCC HTB-137)
EFO_0006589 Hs 746T human gastric carcinoma cell line from a 74 year old Caucasian male (ATCC HTB-135)
EFO_0006590 Hs 766T human pancreatic carcinoma from a 46 year old Caucasian male (ATCC HTB-134)
EFO_0006591 Hs 839.T human melanoma cell line from a 42 year old Caucasian female (ATCC CRL-7572)
EFO_0006592 Hs 852.T human melanoma cell line from a 53 year old Asian male (ATCC CRL-7585)
EFO_0006593 Hs 895.T human melanoma cell line from a 48 year old Caucasian female (ATCC CRL-7637)
EFO_0006594 Hs 936.T human melanoma cell line from a male (ATCC CRL-7686)
EFO_0006595 Hs 940.T human melanoma cell line from a 57 year old Caucasian male (ATCC CRL-7691)
EFO_0006596 HuP-T3 human pancreatic adenocarcinoma cell line derived from an ascites sample taken from a 66 year old Japanese male with a poorly differentiated pancreatic adenocarcinoma (Sigma catlaog number 93121055)
EFO_0006597 IGR-37 human melanoma established from the lymph node metastasis (groin) of a 26-year-old man with malignant melanoma (primary tumor histology: SSM level IV) (DSMZ catalog number ACC 237)
EFO_0006598 IM95m human stomach adenocarcinoma cell line from a 63 year old Japanese male with moderately differentiated adenocarcinoma of stomach
EFO_0006599 JHH-1 human hepatocellular carcinoma cell line from a 50 year old Japanese male with complication of hepatic cirrhosis and hepatocellular carcinoma
EFO_0006600 JHH-2 human hepatocellular carcinoma cell line from a 57 year old Japanese male with hepatocellular carcinoma
EFO_0006601 JHH-4 human hepatocellular carcinoma cell line from a 51 year old Japanese male with hepatocellular carcinoma
EFO_0006602 JHH-5 human hepatocellular carcinoma cell line from a 50 year old male with small liver cancer observed in the chronic hepatitis
EFO_0006603 JHH-7 human hepatocellular carcinoma cell line from a 53 year old male with HBs-Ag positive hepato cellular carcinoma (Ed.III) with liver cirrhosis
EFO_0006604 JJ012 human chondrosarcoma cell line
EFO_0006605 JJN-3 human leukemia cell line established from the bone marrow of a 57-year-old woman with plasma cell leukemia (IgA1kappa) at diagnosis in 1987 (DSMZ catalog number ACC 541)
EFO_0006606 KARPAS 1106P human B-cell lymphoma cell line established from a pleural effusion of a 23 year old women with mediastinal lymphoblastic B-cell non-Hodgkin′s lymphoma (Sigma catalog number 06072607)
EFO_0006607 Kasumi-1 human acute myeloid leukemia cell line established from the peripheral blood of a 7-year-old Japanese boy with acute myeloid leukemia (AML FAB M2) (in 2nd relapse after bone marrow transplantation) in 1989 (DSMZ catalog number AAC 2200
EFO_0006608 KCI-MOH1 human pancreatic adenocarcinoma cell line from the moderately differentiated adenocarcinoma of the head of the pancreas from a 74-year-old African-American man in 1996 (DSMZ catalog number ACC 498)
EFO_0006609 KHM-1B human multiple myeloma cell line established from a pleural effusion of a 53 year old man with IgA lambda multiple myeloma with hyperamylasemia
EFO_0006610 KLM-1 human pancreatic carcinoma cell line
EFO_0006611 KMM-1 human multiple myeloma cell line from a 62 year old Japanese male
EFO_0006612 KMS-12-BM human multiple myeloma cell line established from the bone marrow of a 64-year-old woman with multiple myeloma in 1988 (DSMZ catalog number ACC 551)
EFO_0006613 KMS-12-PE human multiple myeloma cell line established from the bone marrow of a 64-year-old woman with multiple myeloma in 1988
EFO_0006614 KMS-21-BM human multiple myeloma cell line from a 62 year old Japanese male
EFO_0006615 KMS-26 human multiple myeloma cell line from a 50 year old Japanese male
EFO_0006616 KMS-27 human multiple myeloma cell line from a 52 year old Japanese male
EFO_0006617 KMS-28BM human multiple myeloma cell line from a 77 year old female
EFO_0006618 KMS-28PE human multiple myeloma cell line from a 77 year old Japanese female
EFO_0006619 KMS-34 human multiple myeloma cell line from a 60 year old Japanese female
EFO_0006620 KNS-62 human non-small cell lung carcinoma line established from a 49 year old male patient with a non-small cell lung carcinoma
EFO_0006621 KP-2 human pancreatic carcinoma cell line established from a 50 year old Japanese male with pancreatic ductal cell carcinoma
EFO_0006622 KP-3 human pancreatic adenosquamous carcinoma cell line from a 75 year old Japanese male
EFO_0006623 KP-4 human pancreatic ductal carcinoma cell line from a 50 year old Japanese male
EFO_0006624 KPL-4 human breast ductal adenocarcinoma cell line from a 52 year old Japanese female
EFO_0006625 KURAMOCHI human ovarian carcinoma from a Japanese female with ovarian cancer, undifferentiated carcinoma
EFO_0006626 KYSE-140 human esophageal squamous carcinoma cell line derived from the moderately differentiated invasive esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 54-year-old Japanese man prior to treatment (DSMZ catalog number ACC 348)
EFO_0006627 KYSE-150 human esophageal squamous carcinoma cell line established from the poorly differentiated esophageal squamous cell carcinoma resected from upper (cervical) esophagus of a 49-year-old Japanese woman after receiving radiotherapy (DSMZ catalog number ACC 375)
EFO_0006628 KYSE-180 human esophageal squamous carcinoma cell line established from the well differentiated esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 53-year-old Japanese man prior to treatment (DSMZ catalog number ACC 379)
EFO_0006629 KYSE-270 human esophageal squamous carcinoma cell line derived from well differentiated invasive esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 79-year-old Japanese man prior to treatment (DSMZ catalog number ACC 380)
EFO_0006630 KYSE-450 human esophageal squamous carcinoma cell line established from the well differentiated invasive eosphageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 59-year-old Japanese man prior to treatment (DSMZ catalog number ACC 387)
EFO_0006631 KYSE-510 human esophageal squamous carcinoma cell line established from the well-differentiated eosphageal squamous cell carcinoma with moderate invasion of the adventitia resected from cervical esophagus of a 67-year-old Japanese woman after cisplatin and radiotherapy (DSMZ catalog number ACC 374)
EFO_0006632 KYSE-520 human esophageal squamous carcinoma cell line established from the moderately differentiated invasive eosphageal squamous cell carcinoma resected from lower intra-thoracic esophagus of a 58-year-old Japanese woman prior to treatment (DSMZ catalog number ACC 371)
EFO_0006633 KYSE-70 human esophageal squamous carcinoma cell line established from the poorly differentiated invasive esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 77-year-old Japanese man prior to treatment (DSMZ catalog number ACC 363)
EFO_0006634 LCLC-103H human large cell lung carcinoma cell line established from the pleural effusion of a 61-year-old Caucasian man with large cell lung carcinoma with giant cells who had received chemo- and radiotherapy (DSMZ catalog number ACC 384)
EFO_0006635 LCLC-97TM1 human large cell lung carcinoma cell line that represents the xenotransplant of a primary tumor which was obtained from a 44-year-old Caucasian man with large cell lung carcinoma who did not have any prior therapy (DSMZ catalog number ACC 388)
EFO_0006636 LN-18 human brain glioblastoma cell line from a 65 year old male of white ethnicity (ATCC CRL-2610)
EFO_0006637 LN-229 human brain glioblastoma cell line from a 60 year old female of white ethnicity (ATCC CRL-2611)
EFO_0006638 LOU-NH91 human lung squamous carcinoma cell line established from the lower right lung lobe removed two months after diagnosis of highly differentiated squamous cell lung carcinoma with metastasis to one lymph node (no visceral involvement) in a 64-year-old woman (DSMZ catalog number ACC 393)
EFO_0006639 LoVo human colorectal adenocarcinoma cell line established from the metastatic nodule resected from a 56-year-old Caucasian man with colon adenocarcinoma in 1972 (DSMZ catalog number ACC 350)
EFO_0006640 LS 180 human colorectal adenocarcinoma cell line from a 58 year old Caucasian female (ATCC CL-187)
EFO_0006641 LXF-289 human lung adenocarcinoma established from the lung adenocarcinoma of a 63 year old male (DSMZ catalog number ACC 265)
EFO_0006642 LXFL529 human non-small cell lung carcinoma cell line
EFO_0006643 MCF10DCIS.COM clonal breast cancer cell line derived from a xenograft originating from premalignant MCF10AT cells
EFO_0006644 MDST8 human colon carcinoma cell line establlished from human colorectal tumor explants (Sigma catalog number 99011801)
EFO_0006645 ME-1 human acute myeloid leukemia cell line established from the peripheral blood of a 40-year-old Japanese man with acute myeloid leukemia (AML) FAB M4eo at second relapse in 1988 (DSMZ catalog number ACC 357)
EFO_0006646 ME-180 human epidermoid carcinoma cell line from a 66 year old Caucasian female (ATCC HTB-33)
EFO_0006647 MEL-HO human skin melanoma cell line established from the primary tumor of a woman with melanoma in 1976 (DSMZ catalog number ACC 62)
EFO_0006648 MeWo human skin melanoma cell line from a 78 year old Caucasian male
EFO_0006649 MFM-223 human mammary carcinoma cell line obtained from the pleural effusion of a postmenopausal breast cancer patient (Sigma catalog number 98050130)
EFO_0006650 MHH-ES-1 human Ewings' sarcoma cell line established from the ascites of a 12-year-old Turkish boy with Ewing's sarcoma of the left pelvis (with peritoneal metastasis) (DSMZ catalog number ACC 167)
EFO_0006651 MHH-NB-11 human brain neuroblastoma cell line established from a neuroblastoma metastasis at an adrenal site of a 4-year-old white boy in 1986 (DSMZ catalog number ACC 157)
EFO_0006652 MOLM-16 human acute myeloid leukemia cell line established in 1999 from the peripheral blood of a 77-year-old Japanese woman at relapse of acute myeloid leukemia (DSMZ catalog number ACC 555)
EFO_0006653 MOLP-2 human multiple myeloma cell line established from the peripheral blood of a 55-year-old man with IgD lambda type multiple myeloma in 1991 (DSMZ catalog number ACC 607)
EFO_0006654 MOLP-8 human multiple myeloma cell line established from the peripheral blood of a 52-year-old Japanese man with multiple myeloma (stage IIIA, type IgD lambda) in 2002 (DSMZ catalog number ACC 569)
EFO_0006655 MOR human lung adenocarcinoma cell line (Sigma catalog number 84112312)
EFO_0006657 NCI-H1373 human lung adenocarcinoma cell line from a 56 year old African male
EFO_0006658 NCI-H1435 human non-small cell lung carcinoma cell line from a 35 year old female (ATCC CRL-5870)
EFO_0006659 NCI-H146 human small cell lung carcinoma cell line established from a 59 year old Caucasian male (ATCC HTB-173)
EFO_0006660 NCI-H1568 human non-small cell lung carcinoma cell line from a 48 year old Caucasian female (ATCC CRL-5876)
EFO_0006661 NCI-H1693 human non-small cell lung carcinoma cell line from a 55 year old Caucasian female (ATCC CRL-5887)
EFO_0006662 NCI-H1734 human non-small cell lung carcinoma cell line from a 56 year old female (ATCC CRL-5891)
EFO_0006663 NCI-H1781 human lung adenocarcinoma cell line from a 66 year old Caucasian female (ATCC CRL-5894)
EFO_0006664 NCI-H1869 human non-small cell lung carcinoma cell line from a 58 year old Caucasian male ATCC CRL-5900)
EFO_0006665 NCI-H1882 human small cell lung carcinoma cell line from a 59 year old Caucasian male (ATCC CRL-5903)
EFO_0006666 NCI-H1915 human non-small cell lung carcinoma cell line from a 61 year old Caucasian female (ATCC CRL-5904)
EFO_0006667 NCI-H1944 human non-small cell lung carcinoma cell line from a 62 year old Caucasian female (ATCC CRL-5907)
EFO_0006668 NCI-H196 human small cell lung carcinoma cell line from a 68 year old Caucasian male (ATCC CRL-5823)
EFO_0006669 NCI-H2023 human non-small cell lung carcinoma cell line from a 26 year old Caucasian male (ATCC CRL-5912)
EFO_0006670 NCI-H2073 human lung adenocarcinoma cell line from a 47 year old Caucasian female (ATCC CRL-5918)
EFO_0006671 NCI-H209 human small cell lung carcinoma cell line from a Caucasian male (ATCC HTB-172)
EFO_0006672 NCI-H2106 human non-small cell lung carcinoma cell line from a 58 year old Caucasian male (ATCC CRL-5923)
EFO_0006673 NCI-H2110 human non-small cell lung carcinoma cell line (ATCC CRL-5924)
EFO_0006674 NCI-H2135 human non-small cell lung carcinoma cell line (ATCC CRL-5926)
EFO_0006675 NCI-H2172 human non-small cell lung carcinoma cell line established from a female (ATCC CRL-5930)
EFO_0006676 NCI-H2196 human small cell lung carcinoma cell line from a 67 year old Caucasian male (ATCC CRL-5932)
EFO_0006677 NCI-H2198 human small cell lung carcinoma cell line from a 67 year old Caucasian male (ATCC CRL-5933)
EFO_0006678 NCI-H2369 human lung mesothelioma cell line
EFO_0006679 NCI-H2373 human lung mesothelioma cell line
EFO_0006680 NCI-H2452 human lung mesothelioma cell line (ATCC CRL-5946)
EFO_0006681 NCI-H2461 human lung mesothelioma cell line
EFO_0006682 NCI-H2595 human lung mesothelioma cell line
EFO_0006683 NCI-H2596 human lung mesothelioma cell line
EFO_0006684 NCI-H2722 human lung mesothelioma cell line
EFO_0006685 NCI-H2795 human lung mesothelioma cell line
EFO_0006686 NCI-H28 Human lung carcinoma
EFO_0006687 NCI-H2803 human lung mesothelioma cell line
EFO_0006688 NCI-H2804 human lung mesothelioma cell line
EFO_0006689 NCI-H2810 human lung mesothelioma cell line
EFO_0006690 NCI-H292 human pulmonary mucoepidermoid carcinoma cell line derived from a cervical node metastasis of a pulmonary mucoepidermoid carcinoma from a 32 year old female (SIGMA catalog number 91091815)
EFO_0006691 NCI-H322T human non-small cell lung carcinoma cell line
EFO_0006692 NCI-H345 human small cell lung carcinoma cell line from a 64 year old Caucasian male (ATCC HTB-180)
EFO_0006693 NCI-H510A human small cell lung carcinoma cell line from a 56 year old Caucasian male (ATCC HTB-184)
EFO_0006694 NCI-H596 human adenosquamous lung carcinoma cell line from a 73 year old Caucasian male (ATCC HTB-178)
EFO_0006695 NCI-H727 human non-small cell lung carcinoma cell line from the lung of a 65 year old Caucasian female with a non-small cell lung carcinoma, prior to treatment (SIGMA catalog number 94060303)
EFO_0006696 NCI-H847 human small cell lung carcinoma cell line from a 63 year old Caucasian male (ATCC CRL-5846)
EFO_0006697 NCI-H889 human small cell lung carcinoma cell line from a 69 year old Caucasian female (ATCC CRL-5817)
EFO_0006698 NCI-H920 human non-small cell lung carcinoma cell line from a 43 year old Caucasian male (ATCC CRL-5850)
EFO_0006699 NOF151 human normal ovarian fibroblast cell line
EFO_0006700 NU-DUL-1 human B-cell non-Hodgkin lymphoma cell line established in 1982 from the cerebrospinal fluid of a 43-year-old Caucasian man with B-cell non-Hodgkin lymphoma (DSMZ catalog number ACC 579)
EFO_0006701 NUGC-2 human stomach adenocarcinoma cell line from a 56 year old female
EFO_0006702 NUGC-3 human stomach adenocarcinoma cell line from a 72 year old male
EFO_0006703 NUGC-4 human stomach adenocarcinoma cell line from a 35 year old female
EFO_0006704 OAW28 human ovarian serous cystadenocarcinoma cell line from an ascites of patient with ovarian cystadenocarcinoma (Sigma catalog number 85101601)
EFO_0006705 OAW42 human ovarian serous cystadenocarcinoma cell line from an ascites of patient with ovarian cystadenocarcinoma (Sigma catalog number 85073102)
EFO_0006706 OCI-AML2 human acute myeloid leukemia cell line established from the peripheral blood of a 65-year-old man with acute myeloid leukemia (AML FAB M4) in 1986 (DSMZ catalog number ACC 99)
EFO_0006707 OCI-AML5 human acute myeloid leukemia cell line established from the peripheral blood of a 77-year-old man with acute myeloid leukemia (AML M4) in relapse in 1990 (DSMZ catalog number ACC 247)
EFO_0006708 OCI-LY10 human B-cell non-Hodgkin lymphoma cell line established from the bone marrow of a 44-year-old man with B-cell non-Hodgkin lymphoma (B-NHL; diffuse large cell), stage 4B at relapse in 1983 (DSMZ catalog number ACC 722)
EFO_0006709 OCI-LY19 human B-cell non-Hodgkin lymphoma cell line established from the bone marrow of a 27-year-old woman with B-cell non-Hodgkin lymphoma (B-NHL) in 1987 (DSMZ catalog number ACC 528)
EFO_0006710 OCI-LY3 human B-cell non-Hodgkin lymphoma cell line established in 1983 from the bone marrow sample of a 52-year-old man with B-cell non-Hodgkin lymphoma (DSMZ catalog number Acc 761)
EFO_0006711 OCI-LY7 human B-cell non-Hodgkin lymphoma cell line established from the peripheral blood sample of a 48-year-old man with B-cell non-Hodgkin lymphoma in 1984 (DSMZ catalog number ACC 688)
EFO_0006712 OCI-M1 human acute myeloid leukemia cell line established from erythroleukemia blasts (AML M6) of a 62-year-old patient following a 7-year chlorambucil treatment for chronic lymphocytic leukemia (DSMZ catalog number ACC 529)
EFO_0006713 OCI-M2 human acute myeloid leukemia cell line established in 1984 from the leukemic cells of a 56-year-old patient with erythroleukemia (DSMZ catalog number ACC 619)
EFO_0006714 OCUM-1 human stomach adenocarcinoma cell line from a 38 year old Japanese adult
EFO_0006715 Okajima human stomach adenocarcinoma cell line
EFO_0006716 OPM-2 human multiple myeloma cell line established from the peripheral blood of a 56-year-old woman with multiple myeloma (IgG lambda) in leukemic phase (relapse, terminal) in 1982 (DSMZ catalog number ACC 50)
EFO_0006717 OUMS-23 human colon adenocarcinoma cell line established from a male
EFO_0006720 OVCA420 human ovarian carcinoma cell line established from a female
EFO_0006721 OVCA429 human ovarian adenocarcinoma cell line established from a female
EFO_0006722 OVCA432 human ovarian carcinoma cell line established from a female
EFO_0006723 OVCA433 human ovarian carcinoma cell line
EFO_0006724 OVISE human ovarian carcinoma cell line from a 40 year old Japanese female
EFO_0006725 OVKATE human ovarian adenocarcinoma cell line from a 40 year old Japanese female
EFO_0006726 OVMANA human ovarian adenocarcinoma cell line from a 51 year old Japanese female
EFO_0006727 OVSAHO human ovarian adenocarcinoma cell line from a 56 year old Japanese female
EFO_0006728 OVTOKO human ovarian adenocarcinoma cell line from a 78 year old Japanese female
EFO_0006729 PA-TU-8902 human pancreatic adenocarcinoma cell line
EFO_0006730 PA-TU-8988S human pancreatic adenocarcinoma cell line from a 64 year old female
EFO_0006733 PE/CA-PJ15 human oral squamous carcinoma cell line established from tongue tissue of a 45 year old male patient with oral squamous cell carcinoma (Sigma catalog number 96121230)
EFO_0006734 PK-45H human pancreatic carcinoma cell line
EFO_0006735 PK-45P human pancreatic carcinoma cell line
EFO_0006736 PK-59 human pancreatic carcinoma cell line
EFO_0006737 PK-8 human pancreatic carcinoma cell line
EFO_0006739 PSN1 human pancreatic adenocarcinoma cell line (Sigma catalog number 94060601)
EFO_0006741 QGP-1 human pancreatic carcinoma cell line of islet cell origin
EFO_0006742 RC-K8 human B-cell lymphoma cell line established from the peritoneal effusion of a patient with lymphoma, described at the time as true histiocytic lymphoma, in 1984 (DSMZ catalog number ACC 561)
EFO_0006743 RERF-GC-1B human stomach carcinoma cell line from a 41 year old Japanese male
EFO_0006744 RERF-LC-OK human lung adenocarcinoma cell line
EFO_0006745 RKN human ovarian leiomyosarcoma from a 45 year old Japanese female
EFO_0006746 RMG-I human ovarian mesonephroid adenocarcinoma cell line from a 34 year old Japanese female
EFO_0006747 RMUG-S human ovarian adenocarcinoma cell line from a 62 year old Japanese female
EFO_0006748 RTS3b spontaneously immortalised human epidermal keratinocytes
EFO_0006749 SCLC-21H human small cell lung carcinoma cell line established from the pleural effusion of a 46-year-old Caucasian man with small cell lung carcinoma (DSMZ catalog number ACC 372)
EFO_0006750 SCLC-22H human small cell lung carcinoma cell line established from the pericardial effusion of a 46-year-old Caucasian man with small cell lung carcinoma (DSMZ catalog number ACC 373)
EFO_0006751 SIG-M5 human acute myeloid leukemia cell line established in 1995 from the bone marrow of a 63-year-old man with acute myeloid leukemia of monocytic origin (DSMZ ACC 468)
EFO_0006752 SK-CO-1 human colorectal adenocarcinoma from a 65 year old Caucasian male (ATCC HTB-39)
EFO_0006753 SKM-1 human myelodysplasic cell line established from the peripheral blood of a 76-year-old Japanese man with acute monoblastic leukemia (AML M5) in 1989 following myelodysplastic syndromes (DSMZ catalog number ACC 547)
EFO_0006754 SNU-216 human stomach carcinoma cell line from a 46 year old female
EFO_0006755 SNU-484 human stomach carcinoma cell line from a 53 year old male
EFO_0006756 SNU-601 human stomach carcinoma cell line from a 34 year old male
EFO_0006757 SNU-620 human stomach carcinoma cell line from a 59 year old female
EFO_0006758 SNU-638 human stomach carcinoma cell line from a 48 year old male
EFO_0006759 SNU-668 human stomach carcinoma cell line from a 68 year old male
EFO_0006760 SNU-719 human stomach carcinoma cell line from a 53 year old male
EFO_0006761 SNU-C1 human colon adenocarcinoma cell line from a 71 year old Asian male (ATCC CRL-5972)
EFO_0006762 SUM229PE human breast carcinoma cell line established from a female
EFO_0006763 SUP-B15 human acute lymphoblastic leukemia cell line from a 8 year old Caucasian boy (ATCC CRL-1929)
EFO_0006764 TCC-PAN2 human pancreatic carcinoma cell line from a 68 year old Japanese female
EFO_0006765 TK-10 human carcinoma cell line from kidney of a 46 year old male
EFO_0006766 TYK-nu human ovarian carcinoma cell line
EFO_0006767 TYK-nu.CP-r human undifferentiated carcinoma cell line
EFO_0006768 U-698-M human B-cell lymphoma cell line established from the involved tonsil of a 7-year-old boy with lymphoblastic lymphoma at diagnosis prior to therapy in 1972 (DSMZ catalog number ACC 4)
EFO_0006769 UCSD-242l human skin melanoma cell line
EFO_0006770 UM-UC-1 human bladder transitional carcinoma cell line derived from a bladder cancer metastasis of a black male (Sigma catalog number 06080301)
EFO_0006771 UM-UC-3 human bladder transitional carcinoma cell line from the urinary bladder of a male (ATCC CRL-1749)
EFO_0006773 VMRC-LCD human lung adenocarcinoma cell line from a male
EFO_0006774 WM-266-4 human skin melanoma cell line from a 58 year old female (ATCC CRL-1676)
EFO_0006775 WSU-DLCL2 human B-cell lymphoma cell line derived from the pleural effusion of a 41-year-old Caucasian man with B-cell non-Hodgkin lymphoma (DSMZ catalog number ACC 575)
EFO_0006776 WSU-FSCCL human B-cell lymphoma cell line established from the peripheral blood of a 37-year-old white man with low-grade follicular small cleaved cell lymphoma (DSMZ catalog number ACC 612)
EFO_0006777 WSU-NHL human B-cell lymphoma cell line established from the pleural effusion of a 46-year-old woman with nodular histiocytic lymphoma (refractory, progressive) in 1986 (DSMZ ACC 58)
EFO_0006778 YAPC human pancreatic carcinoma cell line from a 43 year old Japanese male
EFO_0006779 YMB-1 human breast carcinoma cell line from a 55 year old female
EFO_0006780 YMB-1-E human breast carcinoma cell line from a 55 year old female
EFO_0006787 HM7 human colon adenocarcinoma cell line
EFO_0007070 ACC112 ACC112 was established from a salivary glad tumor of a 70-year-old male. Adenoid cystic carcinoma cell line supplied by Lurdes Queimado, M.D., Ph.D. Phone: 405-271-4232 (office); 405-271-4279 (lab); cells immortalized by infection with a retrovirus expressing HPV16 E6 and E7
EFO_0007071 BG01 The hES line BG01 with a normal 46XY karyotype was derived from fibroblasts of an embryonic male human.
EFO_0007073 CyT49 This hESC line was isolated using human feeder cells under good manufacturing process (GMP) conditions. NIH registration: 0041.
EFO_0007074 DND-41 DND-41 was established from the peripheral blood of 13-year-old boy with T-acute lymphoblastic leukemia (T-ALL; type III cortical) in 1977; described to carry CDKN2B (p15INK4B) and CDKN2A (p16INK4A) deletions and TP53 (p53)mutation.
EFO_0007076 ES-I3 The I3 stem cell line was derived from donated blastocysts by removal of the trophoblast layer and further culturing of the intact inner cell mass on mitotically inactivated mouse embryonic fibroblast (MEF) feeder cells. Following injection into SCID mice, the I3 line formed teratomas that contained tissues from all three embryonic germ layers. This line exhibits a normal XX karyotype. These cells were provided by Alex Meissner and maintained in mTeSR medium.
EFO_0007078 HUES13 Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.
EFO_0007079 HUES28 Human embryonic stem cell line with a normal 46XX karyotype, pluripotency tested in vivo (teratoma). The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [PMCID: PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007080 HUES3 Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007081 HUES44 Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.
EFO_0007082 HUES45 Human embryonic stem cell line derived from human blastocysts. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on 10% KOSR (Invitrogen) medium.
EFO_0007083 HUES48 Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, NANOG, and TRA-1-81. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007084 HUES49 Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007085 HUES53 Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, TRA1-60, TRA1-81 and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007086 HUES6 Human embryonic stem cell line with a normal 46XX karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007087 HUES62 Human embryonic stem cell line with a normal 46XX karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007088 HUES63 Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007089 HUES64 Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007091 HUES65 Human embryonic stem cell line with a normal 46XY karyotype. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, and NANOG. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007092 HUES66 Human embryonic stem cell line derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including OCT4, NANOG, and TRA-1-60. [PMCID:PMC3335201]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007093 HUES8 Human embryonic stem cell line with a normal 46XY karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007094 HUES9 Human embryonic stem cell line with an abnormal 46XX, Inv9 karyotype, pluripotency tested in vitro and in vivo. The stem cells were derived from human blastocysts and are strongly positive for a number of molecular markers of undifferentiated pluripotent human stem cells, including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and alkaline phosphatase. [DOI: 10.1056/NEJMsr040330]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007095 iPS DF 19.7 IPS DF 19.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1
EFO_0007096 iPS DF 19.11 Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium.
EFO_0007097 iPS DF 4.7 IPS DF 4.7 cell line is an induced pluripotent stem cell line, derived from newborn foreskin fibroblasts. Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC (Cat# CRL-2097TM). The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. The differentiation method is described here: http://www.sciencemag.org/cgi/content/full/324/5928/797?rss=1
EFO_0007098 iPS DF 6.9 Human induced pluripotent stem cell line line derived from foreskin fibroblasts, isolated as described by Yu, J. et al. Human induced pluripotent stem cell lines free of vector and transgene sequences. Science 324, 797-801 (2009). Cells were received from the James Thomson laboratory, who originally reprogrammed the cells from fibroblasts provided by ATCC. The first set of numbers before the period refer to different clones, the number after the period indicates the sub-clone. Cells were maintained on mTeSR medium.
EFO_0007099 iPS-11a Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [90%]; abnormal, extra marker chr [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007100 iPS-11b Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [95%]; abnormal, 47XY +1 [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007101 iPS-11c Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: normal, 46XY [75%]; abnormal, 46 XY del in chr 2 [25%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium.
EFO_0007102 iPS-15b Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [55%]; Abnormal, +(1)(q25.3) [40%]; trisomy X, +(1)(q25.3) [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007103 iPS-17a Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4. [PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007104 iPS-17b Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007105 iPS-18a Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [90%]; Abnormal, 45XO [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007106 iPS-18b Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007107 iPS-18c Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007108 iPS-20b Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XY [90%]; Abnormal, non clonal tetraploid [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on KSR medium.
EFO_0007109 iPS-27b Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Abnormal, 47XX +17, addition to 9 [80%]; Normal, 46XX [10%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium.
EFO_0007110 iPS-27e Human induced stem cell line derived from dermal fibroblasts. Cells have a karyotype of: Normal, 46XX [95%]; Abnormal, 47XX +17 [5%]. Cells are pluripotency tested on 3 germ layers in EB and teratomas. The cells were reprogrammed using a retrovirus containing 3 factors: KLF4, SOX2, OCT4.[PMID: 21293464]. Cells were provided by Harvard University and maintained on 10% KOSR medium.
EFO_0007111 iPS-5 This induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts, by viral transduction of OCT4, SOX2, KLF4, MYC, hTERT, and SV40 large T (hTERT and SV40 large T did not integrate).
EFO_0007112 Loucy Loucy was established in 1987 from the peripheral blood of a 38-year-old female patient with T-cell acute lymphoblastic leukemia (T-ALL) obtained two months prior to her death. May be of value in evaluating the role of t(16;20) in the etiology of T-ALL.
EFO_0007116 UCSF4 The hESC line UCSF4 with a normal 46XX karyotype was derived from a blastocyst-stage embryo on human foreskin fibroblasts.
EFO_0007599 L1-S8 L1-S8 is a partially reprogrammed cell line generated from human bone marrow mononuclear cells (BMMCs) after prestimulation with early cytokines (TPO, FL, SCF, IL-3) and transduced with Sendai viruses expressing the four factors OCT4, SOX2, KLF4 and cMYC. It originated from a single colony manually picked and clonal expanded.
EFO_0007600 L1-S8R L1-S8R is a human iPSC line derived from L1-S8 after transduction with lentiviral vector pLM-fSV2A (Papapetrou et al NBT 2011) expressing OCT4, SOX2, KLF4 and cMYC.
EFO_0007610 RWPE2 RWPE-2 cells were derived from RWPE-1 cells (ATCC CRL-11609) by transformation with Ki-ras using the Kirsten murine sarcoma virus (Ki-MuSV).
EFO_0007611 SU-DHL-2 Human anaplastic large cell lymphoma cell line, established from the pleural effusion of a 73-year-old female. Most of these cells were hyperdiploid, with a sharp modal number of 51 chromosomes; occasional cells in the hypertetraploid range were also seen. A minute marker chromosome was consistently observed, and increased numbers of chromosomes were seen in the A, B, C, and F groups
EFO_0007752 VCaP Human prostate cancer cell line.
EFO_0007950 GM23338 Induced pluripotent stem cell line; Participant #1 (hu43860C) in the Personal Genome Project: http://www.personalgenomes.org Fibroblast culture from this same subject from which this cell line was made is GM23248and a matching lymphoblast line from this same subject is GM20431.
EFO_0007951 hFib2-iPS4 This induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts, by viral transduction of OCT4, SOX2, KLF4, c-MYC, hTERT, and SV40 Large T antigen transgenes. Cells express pluripotent markers and have a normal karyotype, 46XY.
EFO_0007952 iPS-NIHi11 Induced pluripotent stem cell line isolated from skin sample AG20443.
EFO_0007953 iPS-NIHi7 Induced pluripotent stem cell line isolated from skin sample AG08395.
EFO_0009318 HFFc6 Human foreskin fibroblast cell line immortalized by infection with retroviral constrcuts that expressed the hTERT open reading frame
EFO_0009747 GM25256 Induced pluripotent stem cell line derived from adult skin (leg) fibroblasts; subject clinically normal; wild-type; FISH test: 46, XY.
EFO_0010973 NOZ A human cancer cell line, derived from ascites of a patient of peritonitis carcinomatosa. The patient was diagnosed with adenocarcinoma tubular ++, moderately differentiated. This cell line was composed of polygonal, spindle and round shaped cells.
EFO_0022342 gist882 Human GIST882 cell line with activating Kit mutation (K643E)
EFO_0022343 SH-EP1 cell Human neuroblastoma cell line, established from brain bone marrow tissue from a 4 years old caucasian white with neuroblastoma
EFO_0022344 Val cell Human B-acute lymphoblastic leukemia (B-ALL) cell derived from the bone marrow of a 50-year-old woman with B-ALL; cells were described in the literature to carry the three-way-translocation t(8;14;18) and to overexpress the BCL2 and MYC genes
EFO_0022345 CUTLL1 cell CUTLL1 is a human T-cell lymphoblastic lymphoma cell line derived from a relapsed patient that harbors a t(7;9)(q34;q34) chromosomal translocation resulting in expression of a TCRB-NOTCH1 fusion transcript and aberrant Notch signaling
EFO_0022346 76N cell Normal human mammary epithelial cells
EFO_0022347 GM07166VA7 cell SV40 T-antigen transformed derivative of GM07166 NBS1 fibroblast cells.
EFO_0022348 184A1 cell immortal continuous human mammary epithelial cells
EFO_0022349 BL-60 cell Malignant Burkitt lymphoma cell line BL 60
EFO_0022350 T5-1 An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen (HLA)
EFO_0022351 REN Pleural epithelioid mesothelioma cell line
EFO_0022352 SCC12F2 Normal human epidermal premalignant keratinocyte-derived cell line
EFO_0022353 KMC-1 cholangiocellular (bile duct) carcinoma cell line
EFO_0022354 HBC4 cell Human breast cancer cell line HBC4
EFO_0022355 MDA-Panc-28 cell Human pancreatic adenocarcinoma cell line.
EFO_0022356 MM1-144 Human myeloma cell line MM1-144
EFO_0022357 NZG0906 human glioblastoma primary tumor-derived line cell
EFO_0022358 Fuji cells Human Synovial Sarcoma cell line expressing SYT-SSX2 fusion protein.
EFO_0022359 SK-LC-5 Human lung adenocarcinoma cell line
EFO_0022360 WT47 cells An Epstein-Barr virus (EBV) transformed lymphoblastoid cell line with Human Leukocyte Antigen
EFO_0022361 NA8-MEL cells Human melanoma cell line NA8
EFO_0022362 Me67 cells Human melanoma cell line ME67
EFO_0022363 SLB-1 cells Homo sapiens T cell, HTLV-1 immortalized
EFO_0022364 Mel202 cells Human uveal melanoma cell line Mel202
EFO_0022365 NK3.3 cell Human Natural killer cell
EFO_0022366 WM852 cell Human melanoma cell line WM852
EFO_0022367 D04 cell Human melanoma cell line D04
EFO_0022368 MM415 cell MM415 human melanoma cell line
EFO_0022369 MM485 cell MM485 human melanoma cell line
EFO_0022370 WM1791c cell Human WM1791c melanoma cells
EFO_0022371 PMWK cell Human PMWK melanoma cells
EFO_0022372 UT7 cell Human megakaryoblastic cell line
EFO_0022373 GM09607 cell ATM-/- fibroblast cell line GM09607
EFO_0022389 ECV304 cell Human umbilical cord, endothelial ECV304
EFO_0022390 GM03318 cell Human GM03318 fibroblast obtained from patients with Coffin-Lowry Syndrome (CLS).
EFO_0022391 GM02184 cell Human lymphoblastoid cell line
EFO_0022392 GM05849 cell Human Ataxia telangiectasia fibroblast cell line SV40 transformed.
EFO_0022393 MT2 cell Human T cell, lymphoblast, Human T Lymphotrohpic Virus 1 (HTLV-1) immortalized
EFO_0022398 TF1 cell TF-1 have been derived from a patient with erythroleukaemia. They show complete growth dependency on GM-CSF or IL-3, and carry a homogeneous chromosomal abnormality (54,X).
EFO_0022399 AML-193 cell Human acute monocytic leukemia cell line, established from a 13 years old gir
EFO_0022400 NT2-N cell Human neuronal (NT2N) cells derive from an NT2 human teratocarcinoma cell line
EFO_0022401 SK-N-BE(2) cell The SK-N-BE(2) neuroblastoma cell line was established in November of 1972 from a bone marrow biopsy taken from child with disseminated neuroblastoma after repeated courses of chemotherapy and radiotherapy
EFO_0022402 Saos-2 cell Homo sapiens SAOS-2 cell line established from primary osteogenic sarcoma
EFO_0022403 WS1 cell WS1 is a fibroblast cell isolated from the skin of a Black female donor
EFO_0022404 KM-12C cell Colorectal carcinoma cell line derived from a primary tumor
EFO_0022405 HN-5 Cell Well-differentiated human squamous carcinoma cell line (LICR-LON-HN5)
EFO_0022406 MNT-1 cell Human melanoma cell line
EFO_0022407 AG11395 cell Human Werner Syndrome (WS) cell line transformed with SV40
EFO_0022408 HBL-1 cell HBL-1 (aka human is an EBV-negative B-cell lymphoma cell line established from the pleural effusion of a patient with malignant lymphoma, diffuse, large cell.
EFO_0022409 REH cell Human B cell precursor leukemia REH cells
EFO_0022410 hTERT-HME1 cell hTERT-HME1 non-oncogenic immortalized mammary epithelial cell line
EFO_0022411 BOSC-23 cell Human embryonic kidney cell line
EFO_0022413 ARP-1 cell Human myeloma cell line MM1-144
EFO_0022414 ALL-SIL cell ALL-SIL -Human T-ALL (T cell acute lymphoblastic leukemia) cell line
EFO_0022415 hTERT-HPNE cell Human normal pancreas duct cell line; established from a 52 years old male
EFO_0022416 L-540 cell Human Hodgkin lymphoma cell line, established from the bone marrow of a 20-year-old woman with Hodgkin lymphoma (nodular sclerosis; stage IVB, pre-terminal stage).
EFO_0022417 RWP-1 Human pancreatic adenocarcinoma cell line
EFO_0022418 EJ138 cell Human bladder transitional cell carcinoma cell line
EFO_0022420 PEER cell Human T cell leukemia; established from the peripheral blood of a 4-year-old girl with T cell acute lymphoblastic leukemia (T-ALL) in second relapse in 1977
EFO_0022421 T1 (174 x CEM.T1) cell Human lymphoblastoid cell line
EFO_0022422 Eca-109 cell Human esophageal squamous carcinoma cell line
EFO_0022423 YT cell Human T/NK cell leukemia cell line, established from the pericardial fluid of a 15-year-old man with acute lymphoblastic leukemia (ALL) at relapse (with accompanying thymoma) in 1983
EFO_0022424 SK-MEL-37 cell Human cell line established from a metastatic melanoma
EFO_0022425 RHEK-1 cell The human epidermal keratinocyte line, designated RHEK-1, was used at passage 23 for these transformation studies. This cell line was established from primary foreskin epidermal keratinocytes after infection with the Adl2-SV40 hybrid virus
EFO_0022426 M-07E cell A subline of the M-07 human megakaryoblastic leukemia cell line
EFO_0022427 TOV-21G cell Human ovary cancer cell line
EFO_0022428 KOPN-8 cell Human B cell precursor leukemia cell line (MLL-ENL fusion)
EFO_0022429 MUM-2B cell Highly invasive human uveal melanoma line
EFO_0022430 RCC-4 cell Renal cell carcinoma cell line stably transfected with an empty expression vector, pcDNA3, conferring neomycin resistance
EFO_0022431 HOSE cell Human ovarian surface epithelial cell line.
EFO_0022432 2fTGH cell The human sarcoma cell line HT 1080 was transfected with a vector encoding the selectable marker guanine phosphoribosyltransferase regulated by alpha interferon to create the 2fTGH cell line, enabling the selection of mutations in genes encoding components of the interferon signalling pathway
EFO_0022433 C8161.9 cell Human highly metastatic melanoma cell line
EFO_0022434 MEL-JUSO cell Human melanoma, established from the primary tumor of a 58-year-old woman with melanoma in 1977
EFO_0022435 CL1-0 cell Human lung adenocarcinoma cell line. The human lung cancer cell line CL1 was established from a 64-years-old man with a poorly differentiated adenocarcinoma
EFO_0022436 CL1-5 cell Human lung adenocarcinoma cell line
EFO_0022437 LIM1215 cell Human colonic cancer cell line
EFO_0022438 NCCIT cell Human pluripotent embryonal carcinoma, teratocarcinoma cell line; established in 1985 from a mediastinal mixed germ cell tumor of an adult Japanese male. This pluripotent stem cell line is capable of somatic and extraembryonic differentiation
EFO_0022439 ML-1 cell Human acute myeloblastic leukaemia cell line from human peripheral blood
EFO_0022440 KGN cell A steroidogenic human ovarian granulosa-like tumor cell line, from a patient with invasive ovarian granulosa cell carcinoma
EFO_0022441 TGW cell Human TGW neuroblastoma cells
EFO_0022442 PC-3M cell Human prostate cancer cell line.
EFO_0022443 553B-mel Human metastatic melanoma cell line
EFO_0022444 KP-L-RY Human infant acute lymphoblastic leukemia cell line
EFO_0022445 LCL2 Human lymphoblastoid cell line 2, in vitro transformed EBV-positive
EFO_0022446 MOLM-14 cell Human acute myeloid leukemia cell line. Sister cell line of MOLM-13 cell
EFO_0022447 U-343MG cell Human glioblastoma cell line
EFO_0022448 GripTite 293 MSR cell The GripTite™ 293 MSR Cell Line is a genetically engineered Human Embryonic Kidney (HEK 293) cell line that expresses the human macrophage scavenger receptor and strongly adheres to standard tissue culture plates for dependable results
EFO_0022449 RCC-10 cell Human renal clear cell carcinoma cell line.
EFO_0022450 HB1119 cell Human acute lymphoblastic leukemia cell line
EFO_0022451 AT3ABR cell Human ataxia telangiectasia lymphoblastoid cell line
EFO_0022452 Mel-RM cell Human melanoma cell line
EFO_0022454 3A(tPA-30-1) cell human placenta-derived cell line
EFO_0022455 BE3 Human esophagus adenocarcinoma cell line
EFO_0022457 VMRC-RCW cell Human renal carcinoma cell line
EFO_0022458 HPB-ALL cell Human T cell leukemia cell line; established from the peripheral blood of a 14-year-old Japanese boy with ALL and thymoma at diagnosis in 1973
EFO_0022459 CWR-22 cell Androgen-dependent human prostate cancer cell line.
EFO_0022461 HEK-293FT cell The 293FT cell line is a fast-growing, highly transfectable clonal isolate derived from human embryonal kidney cells transformed with the SV40 large T antigen
EFO_0022462 NOMO-1 cell Human acute myeloid leukemia cell line; established from the bone marrow of a 31-year-old woman with acute myeloid leukemia at 2nd relapse
EFO_0022497 SNG-M Human endometrial adenocarcinoma cell line
EFO_0022498 HT-H Human teratocarcinoma cell line
EFO_0022499 M426 SV40T transformed human diploid fibroblast
EFO_0022500 P493-6 Human Burkitt's lymphoma cell line.
EFO_0022502 NB-1 Human neuroblastoma cell line
EFO_0022503 92-1 Human uveal melanoma
EFO_0022504 SW707 Human colorectal adenocarcinoma cell line
EFO_0022505 SYO-1 Human synovial sarcoma cell line
EFO_0022511 CCD-1070Sk Human foreskin fibroblasts
EFO_0022512 KN73 Human hepatoma cell line
EFO_0022514 A-375P Human melanoma cell line
EFO_0022515 HEK-293S Human HEK-293S cell line
EFO_0022516 2C4 gamma2A Human fibrosarcoma cell line
EFO_0022518 CH7C17 Human acute lymphoblastic leukemia cell line
EFO_0022519 GM847 Human SV40-immortalized skin fibroblast cell line, telomerase-negative
EFO_0022520 CHRF-288 Human acute megakaryoblastic leukemia cell line
EFO_0022521 D54 Human melanoma cell line
EFO_0022522 DKO-1 Human colon adenocarcinoma cell line
EFO_0022523 KBM-3 Human acute myelomonocytic leukemia cell line with FLT3 ITD
EFO_0022524 EUFA1341 SV40-transformed skin fibroblast cell line derived from an FA-N patient with biallelic mutations in PALB2, a nonsense mutation (c.1802T>A, p.Y551*) on one allele and a loss of the other allele due to a genomic deletion, which result in the expression of a truncated PALB2 protein lacking the ability to bind BRCA2 and recruit BRCA2-RAD51 following DNA damage.
EFO_0022525 Hana3A Human fetal kidney cell line
EFO_0022526 HCC2429 Human lung non-small cell carcinoma cell line
EFO_0022527 HCS-2/8 Human chondrosarcoma cell line
EFO_0022531 HTC75 Human fibrosarcoma cell line
EFO_0022536 SKLU-1 Human non-small cell lung cancer cell line
EFO_0022538 Yamato-SS Human synovial sarcoma cell line bearing the SS18-SSX1 chromosomal translocation
EFO_0022539 hTERT-RPE1 The hTERT-immortalized retinal pigment epithelial cell line, hTERT RPE-1, was derived by transfecting the RPE-340 cell line with the pGRN145 hTERT-expressing plasmid
EFO_0022540 J.CaM2.5 Human T-cell acute lymphoblastic leukemia cell line
EFO_0022541 JPM50.6 Human Jurkat T-cell leukemia cell line
EFO_0022542 J14 Human Jurkat J14 T-cell leukemia cell line
EFO_0022543 Kit225 Human T-cell prolymphocytic leukemia cell line
EFO_0022544 KK-47 Human urinary bladder transitional cell carcinoma cell line
EFO_0022545 KT-1 Human chronic myelogenous leukemia cell line
EFO_0022549 MRC-5V1 Human lung fibroblast cell line transformed with simian virus 40, MRC-5 cells are their untransformed progenitors
EFO_0022550 NKL Human Natural killer cell lymphoblastic leukemia/lymphoma cell line
EFO_0022551 HK-1 Human EBV-negative nasopharyngeal carcinoma cell line
EFO_0022552 PAXC002 Human gemcitabine-resistant pancreatic cancer cell line
EFO_0022555 GM00232 Human spinal muscle atrophy fibroblast cell
EFO_0022556 TIG-3 Human embryonic lung fibroblast cell line.
EFO_0022557 WHCO6 Human esophageal squamous cell carcinoma cell line
EFO_0022558 WM-35 Human melanoma cell line, derived from the primary radial growth phase tumor site.
EFO_0022559 WM278 This cell line was established from skin taken from a patient with primary nodular melanoma in vertical growth phase.
EFO_0022565 KCL-22 A Philadelphia chromosome-positive cell line established from peripheral blood of a patient with chronic myelogenous leukemia in blast crisis
EFO_0022566 SW13/cl.2 vim- Adrenal cortex carcinoma cell line that does not express vimentin
EFO_0022567 Aska-SS Human synovial sarcoma cell line bearing the SS18-SSX1 chromosomal translocation
EFO_0022568 HEK-293-Flp-In Immortal human kidney-derived derived from the 293 cell line
EFO_0022569 48BR Human primary fibroblast cell line
EFO_0022570 AG02603 Human lung-derived fibroblast cell line
EFO_0022571 ONS-76 Human medulloblastoma cell line
EFO_0022572 MED-MEB-8A Human medulloblastoma cell line
EFO_0022573 CLB-SAV Human lobular breast carcinoma cell line
EFO_0022574 Rh-4 Human alveolar rhabdomyosarcoma cell line
EFO_0022575 TYS Human salivary gland adenosquamous carcinoma cell line
EFO_0022576 EC-9706 Human esophageal carcinoma cell line
EFO_0022577 D-270MG Human glioblastoma cell line
EFO_0022578 G-292 Human osteosarcoma cell line
EFO_0022580 BL-41 Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma
EFO_0022583 SNU-251 Human ovarian endometrial cancer cell line
EFO_0022584 SACC-LM Human salivary gland adenoid cystic carcinoma cell line
EFO_0022586 M249 Human melanoma cell line BRAF V600E mutation
EFO_0022587 HKB-11 Human somatic cell hybridoma (fused human embryonic kidney cells (293S) and modified Burkitt's lymphoma cells (2B8))
EFO_0022588 EUFA143 Human Fanconi anemia cell line
EFO_0022589 EUFA121 Human Fanconi anemia cell line
EFO_0022592 CAL-33 Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy).
EFO_0022593 YTS-Eco Human NK cell lymphoblastic leukemia/lymphoma cell line
EFO_0022594 HCN-1A Human cortical neuronal cell line, established from a 18 months old female patient that suffered from unilateral megalencephaly.
EFO_0022595 PNT2 Human normal prostate epithelium cell line immortalized with SV40.
EFO_0022616 BD-215 Human Fanconi anemia cell line
EFO_0022617 MM200 Human melanoma cell line
EFO_0022618 MGR3 Human glioblastoma cell line
EFO_0022619 Rh-28 Human alveolar rhabdomyosarcoma cell line
EFO_0022620 CFBE41o- Human Cystic fibrotic bronchial epithelial cell line
EFO_0022621 OECM-1 Human oral squamous cell carcinoma cell line
EFO_0022622 LCL 721.221 Human lymphoblastoid cell line
EFO_0022623 SOSP-9607 Human osteosarcoma cell line
EFO_0022625 ST-1 Human adult T cell lymphoma cell line
EFO_0022626 C666 Human nasopharyngeal carcinoma cell line
EFO_0022627 U-178MG Human astrocytoma cell line
EFO_0022629 TPC-1 Human papillary thyroid carcinoma cell line
EFO_0022630 AC16 Human hybrid cardiomyocyte
EFO_0022632 2BS Human transformed human fetal lung cell line
EFO_0022633 IHCF Human immortalized corneal fibroblast
EFO_0022634 H157 Human oral squamous cell carcinoma cell line
EFO_0022635 PRIESS EBV-transformed human lymphoblastoid cell line
EFO_0022636 FET Human colorectal cancer cell line
EFO_0022637 T47D:A18 Human invasive breast carcinoma
EFO_0022638 SK-UT-2 Human endometrial carcinoma cell line
EFO_0022639 MO3.13 Human hybrid cell line that express phenotypic characteristics of primary oligodendrocytes
EFO_0022640 SAVC Human B-lymphoblastoid cell line
EFO_0022641 BM9 Human B-lymphoblastoid cell line
EFO_0022642 PLH Human B-lymphoblastoid cell line
EFO_0022643 BON-1 Human pancreatic neuroendocrine tumor cell line
EFO_0022644 PH5CH8 Human hepatocyte cell line
EFO_0022645 CWR-R1 Human prostate carcinoma cell line
EFO_0022646 HER911 Human embryonic retinoblasts
EFO_0022647 C-28/I2 Immortalized human chondrocyte cell line
EFO_0022648 253J-BV Highly metastatic variant from human transitional cell carcinoma
EFO_0022649 KHYG-1 Human natural killer cell leukemia
EFO_0022650 UPCI-SCC-131 Human oral squamous cell carcinoma cell line
EFO_0022651 IHKE-1 Human immortalized kidney epithelial cell line
EFO_0022652 C3ABR Human lymphoblastoid cell line
EFO_0022653 Hs-578Bst Human breast epithelial cell line
EFO_0022654 MLS 2645-94 Human myxoid liposarcoma cell line
EFO_0022655 MLS 402-91 Human myxoid liposarcoma cell line
EFO_0022657 HOM-2 Human B-lymphoblastoid cell line
EFO_0022658 TE-1 Human esophageal squamous cell carcinoma cell line
EFO_0022659 EoL-1 Human eosinophilic leukaemia cell line
EFO_0022660 PITOUT Human lymphoblastoid cell line
EFO_0022661 LCL1 Human lymphoblastoid cell line
EFO_0022662 OSU-2 Human fibroblast cell line
EFO_0022663 HuH-7-Lunet Human hepatocellular carcinoma cell line
EFO_0022664 Colo-320 Human colorectal cancer cell line
EFO_0022665 SF-188 Human glioma cell line
EFO_0022667 RCB2099 immortal human esophagus-derived cell line
EFO_0022668 OVCAR-10 Human ovarian carcinoma cell line
EFO_0022669 8505C Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma
EFO_0022670 UWR1 Human anaplastic astrocytoma cell line
EFO_0022671 UWR2 Human glioblastoma cell line
EFO_0022672 GES-1 Human normal gastric epithelial cell line
EFO_0022673 BHP5-16 Human amelanotic melanoma cell line
EFO_0022674 K1 Human thyroid gland papillary carcinoma cell line
EFO_0022675 NCI-H3122 immortal human lung-derived cell line
EFO_0022676 SW-1736 Human anaplastic thyroid cancer cell line
EFO_0022677 5-8F High tumorigenic and metastatic subline of SUNE-1 cell line
EFO_0022678 HCCLM-3 Human hepatocellular carcinoma cell line
EFO_0022679 SACC-83 Human salivary gland adenoid cystic carcinoma
EFO_0022680 T2 Human-human somatic cell hybrid cell line, established by PEG-mediated fusion of the B-lymphoblastoid cell line LCL 721.174 with an 8-azaguanine and ouabain-resistant variant of the T-LCL CEM. Subclone of the T1 cell line which has lost both CEM(R)-derived copies of chromosome 6
EFO_0022681 SO-Rb50 Human retinoblastoma cell line
EFO_0022682 Flp-In-T-REx T-REx cell derivative with targeted integration of a Flp-In expression vector
EFO_0022683 T-REx-HeLa Human papillomavirus-related cervical adenocarcinoma
EFO_0022684 T/C-28a2 Human chondrocyte cell line
EFO_0022685 PER.C6 transformed human retinoblast cell line
EFO_0022686 HEK293S GnTI- N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
EFO_0022687 HuTu-80 Human duodenal adenocarcinoma cell line
EFO_0022688 LAN-5 Human neuroblastoma cell line
EFO_0022689 FU-OV-1 Human ovarian serous adenocarcinoma cell line
EFO_0022690 697 Human acute lymphoblastic leukemia cell line
EFO_0022691 BPH-1 Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens
EFO_0022692 IMR-5 Human neuroblastoma cell line
EFO_0022693 HET-1A Human esophageal cell line; derived in 1986 from human esophageal autopsy tissue by transfection with plasmid pRSV-T consisting of the RSV-LTR promoter and the sequence encoding the simian virus 40 large T-antigen
EFO_0022694 MOLM-13 Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes
EFO_0022695 U6A The 2fTGH-U6A Cell Line is part of a panel of IFNy pathway mutant fibrosarcoma cell lines isolated by chemical mutagenesis of IFNy insensitive reporter cells derived from HT1080 cells.
EFO_0022696 HVTs-SM1 Immortalized human vascular smooth muscle cells
EFO_0022697 tsA-201 A transformed human kidney 293 cell line stably expressing an SV40 temperature-sensitive T antigen
EFO_0022698 XPCS2BA XPCS2BA; also has features of Cockayne syndrome; no evidence of malignancy; bilateral sensorineural hearing loss; dry skin; numerous freckles; hyperpigmented macules; broad-based choreoathetotic gait; brother of GM13025; donor subject is homozygous for a T>C transversion in the ERCC3 gene which results in a phenylalanine-99-to-serine missense mutation [PHE99SER (F99S)].
EFO_0022699 RAO-3 RAO-3 was established by transduction of the Q61L mutant RAS into human mammary epithelial cells that were immortalized with catalytic subunit of telomerase (hTERT)
EFO_0022700 EW-7 Human Ewing Sarcoma cell line
EFO_0022701 MCF-7/C4-12 Human invasive breast carcinoma
EFO_0022702 OV-2008 Human cystadenocarcinoma cell line
EFO_0022703 HSC-3 Human oral squamous cell carcinoma cell line
EFO_0022704 NCM-460 Nonmalignant human colonic epithelial cell line
EFO_0022705 U3118MG Human glioblastoma cell line
EFO_0022706 U3082MG Human glioblastoma cell line
EFO_0022707 HKE-3 Clonal derivative from HCT116 colorectal carcinoma cell line, that lacks the mutant k-ras allele
EFO_0022710 Mahlavu Human hepatocellular carcinoma cell line
EFO_0022711 LX-2 Immortalized human hepatic stellate cell line
EFO_0022712 LN-428 Human glioblastoma cell line
EFO_0022713 Nthy-ori 3-1 Human thyroid follicular epithelial cell line
EFO_0022714 LN-308 Human glioblastoma cell line
EFO_0022715 SK-CO15 Human intestinal epithelial cell line
EFO_0022717 8305C Human thyroid carcinoma cell line, established from the primary tumor of a 67-year-old woman with primary thyroid undifferentiated carcinoma
EFO_0022718 TCam-2 Human testicular seminoma cell line
EFO_0022719 RH-41 Human rhabdomyosarcoma cell line
EFO_0022720 MEL-JUSO Human melanoma cell line
EFO_0030018 BLaER1 BLaER1 cell line is a tamoxifen-inducible subclone of the RCH-ACV B-cell leukemia cell line genetically modified using a retrovirus vector to express C/EBPα fused with the estrogen receptor hormone binding domain (ER) and GFP.